Healthier Choices Management (HCMC) 10-K 31 Mar 15 2014 FY Annual report Financial data

Document_and_Entity_Informatio

Document and Entity Information (USD $)	12 Months Ended
	Dec. 31, 2014	Mar. 30, 2015	Jun. 30, 2014
Document And Entity Information
Entity Registrant Name	VAPOR CORP.
Entity Central Index Key	844856
Document Type	10-K
Document Period End Date	31-Dec-14
Amendment Flag	FALSE
Current Fiscal Year End Date	-19
Entity a Well-known Seasoned Issuer	No
Entity a Voluntary Filer	No
Entity's Reporting Status Current	Yes
Entity Filer Category	Smaller Reporting Company
Entity Public Float			$56,301,711
Entity Common Stock, Shares Outstanding		33,635,758
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2014

Consolidated_Balance_Sheets

Consolidated Balance Sheets (USD $)	Dec. 31, 2014	Dec. 31, 2013
CURRENT ASSETS:
Cash	$471,194	$6,570,215
Due from merchant credit card processors, net of reserve for charge-backs of $2,500 and $2,500, respectively	111,968	205,974
Accounts receivable, net of allowance of $369,731 and $256,833, respectively	239,652	1,802,781
Inventories	2,048,883	3,321,898
Prepaid expenses and vendor deposits	664,103	1,201,040
Loans receivable, net	467,095
Deferred financing costs, net	122,209
Deferred tax asset, net		766,498
TOTAL CURRENT ASSETS	4,125,104	13,868,406
Property and equipment, net of accumulated depreciation of $84,314 and $27,879, respectively	712,019	28,685
Other assets	91,360	65,284
TOTAL ASSETS	4,928,483	13,962,375
CURRENT LIABILITIES:
Accounts payable	1,920,135	1,123,508
Accrued expenses	975,112	420,363
Senior convertible notes payable - related parties, net of debt discount of $1,093,750 and $0, respectively	156,250
Current portion of capital lease	-52,015
Term loan	750,000	478,847
Customer deposits	140,626	182,266
Income taxes payable	3,092	5,807
TOTAL CURRENT LIABILITIES	3,997,230	2,210,791
Capital lease, net of current portion	119,443
TOTAL LIABILITIES	4,116,673	2,210,791
COMMITMENTS AND CONTINGENCIES
STOCKHOLDERS' EQUITY:
Preferred stock, $.001 par value, $1,000,000 shares authorized, none issued or outstanding
Common stock, $.001 par value, 50,000,000 shares authorized 16,761,911 and 16,214,528 shares issued and 16,761,911 and 16,214,528 shares outstanding, respectively	16,762	16,214
Additional paid-in capital	16,026,951	13,115,024
Accumulated deficit	-15,231,903	-1,379,654
TOTAL STOCKHOLDERS' EQUITY	811,810	11,751,584
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$4,928,483	$13,962,375

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets (Parenthetical) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Statement of Financial Position [Abstract]
Due from merchant credit card processor, reserve for charge-backs	$2,500	$2,500
Accounts receivable, allowance for doubtful accounts	369,731	256,833
Property and equipment, accumulated depreciation	84,314	27,879
Senior convertible notes payable debt discount net	$1,093,750	$0
Preferred stock, par value	$0.00	$0.00
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock, par value	$0.00	$0.00
Common stock, shares authorized	50,000,000	50,000,000
Common stock, shares issued	16,761,911	16,214,528
Common stock, shares outstanding	16,761,911	16,214,528

Consolidated_Statements_of_Ope

Consolidated Statements of Operations (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Income Statement [Abstract]
SALES, NET	$15,279,859	$25,990,228
Cost of goods sold	14,497,254	16,300,333
GROSS PROFIT	782,605	9,689,895
EXPENSES:
Selling, general and administrative	11,126,759	6,464,969
Advertising	2,374,329	2,264,807
Total operating expenses	13,501,088	8,729,776
Operating (loss) income	-12,718,483	960,119
Other expense:
Induced conversion expense		299,577
Amortization of deferred financing costs	17,458
Interest expense	348,975	383,981
Total other expense	366,433	683,558
(LOSS) INCOME BEFORE INCOME TAX (EXPENSE) BENEFIT	-13,084,916	276,561
Income tax (expense) benefit	-767,333	524,791
NET (LOSS) INCOME	($13,852,249)	$801,352
BASIC (LOSS) EARNINGS PER COMMON SHARE	($0.84)	$0.06
DILUTED (LOSS) EARNINGS PER COMMON SHARE	($0.84)	$0.06
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING - BASIC	16,415,152	12,818,487
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING - DILUTED	16,415,152	13,186,365

Consolidated_Statements_of_Cha

Consolidated Statements of Changes In Stockholders' Equity (USD $)	Common Stock [Member]	Additional Paid-In Capital [Member]	Accumulated Deficit [Member]	Total
Balance at Dec. 31, 2012	$12,038	$1,685,524	($2,181,006)	($483,444)
Balance, shares at Dec. 31, 2012	12,038,163
Issuance of common stock for services	20	86,980		87,000
Issuance of common stock for services, shares	20,000
Issuance of common stock in connection with exercise of stock options	43	70,257		70,300
Issuance of common stock in connection with exercise of stock options, shares	43,300			-43
Stock-based compensation expense		48,239		48,239
Discount on convertible notes to related parties		98,970		98,970
Issuance of common stock for cash, net of offering costs	3,333	9,121,770		9,125,103
Issuance of common stock for cash, net of offering costs, shares	3,333,338
Issuance of common stock upon conversion of debt	780	1,703,707		1,704,487
Issuance of common stock upon conversion of debt, shares	779,727
Induced conversion expense		299,577		299,577
Net income			801,352	801,352
Balance at Dec. 31, 2013	16,214	13,115,024	-1,379,654	11,751,584
Balance, shares at Dec. 31, 2013	16,214,528			16,214,528
Issuance of common stock for services	400	1,602,533		1,602,933
Issuance of common stock for services, shares	400,000
Issuance of common stock in connection with exercise of stock options	5	4,995		5,000
Issuance of common stock in connection with exercise of stock options, shares	5,000			-5
Stock-based compensation expense		163,646		163,646
Induced conversion expense
Offering costs incurred in 2014 pertaining to December 2013 offering		-190,104		-190,104
Issuance of common stock in connection with cashless exercise of warrants	143	-143
Issuance of common stock in connection with cashless exercise of warrants, shares	142,383
Discount on senior convertible notes		1,250,000		1,250,000
Net income			-13,852,249	-13,852,249
Balance at Dec. 31, 2014	$16,762	$16,026,951	($15,231,903)	$811,810
Balance, shares at Dec. 31, 2014	16,761,911			16,761,911

Consolidated_Statements_of_Cas

Consolidated Statements of Cash Flows (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
OPERATING ACTIVITIES:
Net income (loss)	($13,852,249)	$801,352
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Provision for doubtful accounts	112,898	183,333
Depreciation	56,435	11,284
Amortization of deferred debt discount	156,250	102,500
Amortization of deferred financing costs	17,458
Induced conversion expense		299,577
Write down of loan receivable to realizable value	50,000
Write down of obsolete and slow moving inventory	1,834,619
Stock-based compensation	1,766,579	135,239
Utilization of net operating loss carryforward		-346,783
Deferred tax	766,498	-197,585
Changes in operating assets and liabilities:
Due from merchant credit card processors	94,006	838,002
Accounts receivable	1,450,231	-1,250,034
Prepaid expenses and vendor deposits	536,937	-735,180
Inventories	-561,604	-1,651,891
Other assets	-26,076	-53,284
Accounts payable	796,627	-2,085,087
Accrued expenses	554,749	70,212
Customer deposits	-41,640	-295,429
Income taxes	-2,715	53,622
NET CASH USED IN OPERATING ACTIVITIES	-6,290,997	-4,120,152
INVESTING ACTIVITIES:
Loan receivable	-517,095
Purchases of property and equipment	-560,410	14,779
NET CASH USED IN INVESTING ACTIVITIES	-1,077,505	-14,779
FINANCING ACTIVITIES
Proceeds from sale of common stock, net of offering costs	-109,104	9,125,103
Proceeds from senior convertible notes payable to related parties	1,250,000	425,000
Proceeds from senior convertible notes payable		500,000
Deferred financing costs	-139,667
Principal repayments of senior note payable to stockholder		-70,513
Proceeds from term loans payable	1,000,000	750,000
Principal repayments of term loans payable	-728,847	-271,153
Principal repayments of capital lease obligations	-7,901
Proceeds from factoring facility	0	407,888
Principal repayments of factoring facility		-407,888
Proceeds from exercise of stock options	5,000	70,300
NET CASH PROVIDED BY FINANCING ACTIVITIES	1,269,481	10,528,737
INCREASE (DECREASE) IN CASH	-6,009,021	6,393,806
CASH - BEGINNING OF YEAR	6,570,215	176,409
CASH - END OF YEAR	471,194	6,570,215
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
Cash paid for interest	103,068	297,508
Cash paid for income taxes	3,550	13,770
Noncash financing activities:
Issuance of common stock in connection with conversion of notes payable		1,704,487
Cashless exercise of common stock purchase warrants	143
Recognition of deferred debt discount on convertible notes payable	1,250,000	98,970
Purchase of equipment through capital lease obligation	$179,359

Organization_Basis_of_Presenta

Organization, Basis of Presentation and Recent Developments	12 Months Ended
	Dec. 31, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization, Basis of Presentation and Recent Developments	Note 1. ORGANIZATION, BASIS OF PRESENTATION AND RECENT DEVELOPMENTS
	Organization
	Vapor Corp. (the “Company”) is the holding company for its wholly owned subsidiaries Smoke Anywhere U.S.A., Inc. (“Smoke”) and IVGI Acquisition, Inc. The Company designs, markets and distributes vaporizers, e-liquids, electronic cigarettes and accessories under the emagine vapor™, Krave®, VaporX®, Hookah Stix®, Fifty-One® (also known as Smoke 51) and Alternacig® brands. “Vaporizers”, “Electronic cigarettes” or “e-cigarettes,” are battery-powered products that enable users to inhale nicotine vapor without smoke, tar, ash, or carbon monoxide.
	The Company was originally incorporated as Consolidated Mining International, Inc. in 1985 as a Nevada corporation, and the Company changed its name in 1987 to Miller Diversified Corporation whereupon the Company operated in the commercial cattle feeding business until October 31, 2003 when the Company sold substantially all of its assets and became a discontinued operation. On November 5, 2009, the Company acquired Smoke Anywhere USA, Inc., a distributor of electronic cigarettes, in a reverse triangular merger. As a result of the merger, Smoke Anywhere USA, Inc. became the sole operating business. On January 7, 2010, the Company changed its name to Vapor Corp. The Company reincorporated to the State of Delaware from the State of Nevada effective on December 31, 2013.
	Basis of Presentation and Reverse Stock Split
	The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for financial information and with the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”).
	Effective on December 27, 2013, the Company effected a reverse stock split of its common stock at a ratio of 1-for-5. No fractional shares of common stock were issued, and no cash or other consideration were paid as a result of the reverse stock split. Instead, the Company issued one whole share of post-reverse stock split common stock in lieu of each fractional share of common stock. As a result of the reverse stock split, the Company’s share capital was reduced to 51,000,000 shares from 251,000,000 shares, of which 50,000,000 shares are common stock and 1,000,000 shares are “blank check” preferred stock.
	All references in these notes and in the related consolidated financial statements to number of shares, price per share and weighted average number of shares outstanding of common stock prior to the reverse stock split (including the share capital decrease) have been adjusted to reflect the reverse stock split (including the share capital decrease) on a retroactive basis, unless otherwise noted.
	Merger with Vaporin, Inc.
	As fully-disclosed in Note 4 to these consolidated financial statements, on December 17, 2014, the Company entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Vaporin, Inc., a Delaware corporation (“Vaporin”) pursuant to which Vaporin was to merge with and into the Company with the Company being the surviving entity. On the same date, the Company also entered into a joint venture with Vaporin (the “Joint Venture”) through the execution of an operating agreement (the “Operating Agreement”) of Emagine the Vape Store, LLC, a Delaware limited liability company (“Emagine”), pursuant to which the Company and Vaporin were 50% members of Emagine.
	On March 4, 2015, the acquisition of Vaporin by the Company (the “Merger”) was completed pursuant to the terms of the Merger Agreement. In connection with the Merger, Emagine became a wholly-owned subsidiary of the Company.

Going_Concern_and_Management_P

Going Concern and Management Plans	12 Months Ended
	Dec. 31, 2014
Liquidity And Financial Condition [Abstract]
Going Concern and Management Plans	Note 2. GOING CONCERN AND MANAGEMENT PLANS
	The Company’s financial statements for the year ended December 31, 2014 indicate there is substantial doubt about its ability to continue as a going concern as the Company requires additional equity and/or debt financing to continue its operations. The Company must ultimately generate sufficient cash flow to met its obligations on a timely basis, attain profitability in its business operations, and be able to fund its long term business development and growth plans. The Company’s business will require significant amounts of capital to sustain operations and make the investments it needs to execute its longer-term business plan. The Company’s liquidity and capital resources have decreased as a result of the net loss of $13,852,249 that it incurred during the year ended December 31, 2014. At December 31, 2014, the Company’s accumulated deficit amounted to $15,231,903. At December 31, 2014, the Company had working capital of $127,874 compared to $11,657,615 at December 31, 2013, a decrease of $11,529,741. As described in Note 12 (Subsequent Events), on March 4, 2015, the Company and institutional and individual accredited investors entered in a securities purchase agreement pursuant to which the Company issued and sold, in a $3.5 million private placement ($2.9 million in net proceeds), 3,432,314 shares of common stock and warrants to purchase up to 2,735,132 shares of the Company’s common stock. The Company will use the net proceeds from the private placement for working capital. In addition, the Merger with Vaporin also provides an additional financing transaction to occur subsequent to the closing of the Merger for up to $25 million in exchange for common stock and warrants of the Company subject to the Company complying with certain financial covenants and performance-based metrics still to be negotiated.
	The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”), which contemplate continuation of the Company as a going concern and realization of assets and satisfaction of liabilities in the normal course of business. The carrying amounts of assets and liabilities presented in the financial statements do not necessarily purport to represent realizable or settlement values. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.
	The Company’s existing liquidity is not sufficient to fund its operations, anticipated capital expenditures, working capital and other financing requirements for the foreseeable future. We believe we will need to raise additional debt or equity financing to maintain and expand the business. Any equity financing or the issuance of equity equivalents including convertible debt could be dilutive to our shareholders. If either such additional capital is not available on terms acceptable to the Company or at all then the Company may need to curtail its operations and/or take additional measures to conserve and manage its liquidity and capital resources, any of which would have a material adverse effect on our business, results of operations and financial condition.

Summary_of_Significant_Account

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2014
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Note 3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
	Principles of consolidation
	The accompanying consolidated financial statements include the accounts of the Company, its wholly owned subsidiary, Smoke Anywhere USA, Inc., and its 50% joint venture interest in Emagine the Vape Store, LLC. All significant intercompany transactions and balances were eliminated.
	Use of estimates in the preparation of financial statements
	The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of net revenue and expenses during the reporting periods. Actual results could differ from those estimates. These estimates and assumptions include allowances, reserves and write-downs of receivables and inventory, valuing equity securities and hybrid instruments, share-based payment arrangements, deferred taxes and related valuation allowances, and the preliminary valuation of the net assets acquired subsequent to December 31, 2014 in the Merger. Certain of our estimates could be affected by external conditions, including those unique to our industry, and general economic conditions. It is possible that these external factors could have an effect on our estimates that could cause actual results to differ from our estimates. The Company re-evaluates all of its accounting estimates at least quarterly based on these conditions and records adjustments when necessary.
	Revenue recognition
	The Company recognizes revenue from product sales or services rendered when the following four revenue recognition criteria are met: persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, the selling price is fixed or determinable, and collectability is reasonably assured.
	Product sales and shipping revenues, net of promotional discounts, rebates, and return allowances, are recorded when the products are shipped, title passes to customers and collection is reasonably assured. Retail sales to customers are made pursuant to a sales contract that provides for transfer of both title and risk of loss upon the Company’s delivery to the carrier. Return allowances, which reduce product revenue, are estimated using historical experience. Revenue from product sales and services rendered is recorded net of sales and consumption taxes.
	The Company periodically provides incentive offers to its customers to encourage purchases. Such offers include current discount offers, such as percentage discounts off current purchases, inducement offers, such as offers for future discounts subject to a minimum current purchase, and other similar offers. Current discount offers, when accepted by the Company’s customers, are treated as a reduction to the purchase price of the related transaction, while inducement offers, when accepted by its customers, are treated as a reduction to the purchase price of the related transaction based on estimated future redemption rates. Redemption rates are estimated using the Company’s historical experience for similar inducement offers. The Company reports sales, net of current discount offers and inducement offers on its consolidated statements of operations.
	Shipping and Handling Costs
	The Company policy is to provide free standard shipping and handling for most orders shipped during the year. Shipping and handling costs incurred are recognized in selling, general and administrative expenses. Such amounts aggregated $661,583 and $658,586 for the years ended December 31, 2014 and 2013 respectively.
	In certain circumstances, shipping and handling costs are charged to the customer and recognized in sales, net. The amounts recognized for the years ended December 31, 2014 and 2013 were $71,225 and $129,761, respectively.
	Cash and Cash Equivalents
	The Company considers all highly liquid investments with a maturity of three months or less when purchased to be cash equivalents. For financial statement purposes, investments in money market funds are considered a cash equivalent and are included in cash and cash equivalents. The Company maintains its cash and cash equivalents at high credit quality federally insured financial institutions, with balances, at times, in excess of the Federal Deposit Insurance Corporation’s insurance coverage limit of $250,000 per federally insured financial institution. Management believes that the financial institutions that hold the Company’s deposits are financially sound and, therefore, pose a minimum credit risk. The Company has not experienced any losses in such accounts. At December 31, 2014 and 2013, the Company did not hold cash equivalents.
	Accounts Receivable
	Accounts receivable, net is stated at the amount the Company expects to collect. The Company provides a provision for allowances that includes returns, allowances and doubtful accounts equal to the estimated uncollectible amounts. The Company estimates its provision for allowances based on historical collection experience and a review of the current status of trade accounts receivable. It is reasonably possible that the Company’s estimate of the provision for allowances will change.
	Due From Merchant Credit Card Processor
	Due from merchant credit card processor represents monies held by the Company’s credit card processors. The funds are being held by the merchant credit card processors pending satisfaction of their hold requirements and expiration of charge backs/refunds from customers.
	Inventories
	Inventories are stated at the lower of cost (determined by the first-in, first-out method) or market. If the cost of the inventories exceeds their market value, provisions are recorded to write down excess inventory to its net realizable value. The Company’s inventories consist primarily of merchandise available for resale.
	Property and equipment
	Property and equipment is stated at cost less accumulated depreciation. Depreciation is calculated using the straight-line method over the expected useful life of the respective asset, after the asset is placed in service. The Company generally uses the following depreciable lives for its major classifications of property and equipment:
	Description	Useful Lives
	Warehouse fixtures	2 years
	Warehouse equipment	5 years
	Furniture and fixtures	5 years
	Computer hardware	3 years
	Impairment of Long-Lived Assets
	The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying value of the asset may not be recoverable. In connection with this review, the Company also reevaluates the depreciable lives for these assets. The Company assesses recoverability by determining whether the net book value of the related asset will be recovered through the projected undiscounted future cash flows of the asset. If the Company determines that the carrying value of the asset may not be recoverable, it measures any impairment based on the projected future discounted cash flows as compared to the asset’s carrying value. Through December 31, 2014, the Company has not recorded any impairment charges on its long-lived assets.
	Advertising
	The Company expenses advertising cost as incurred.
	Warranty liability
	The Company’s limited lifetime warranty policy generally allows its end users and retailers to return defective purchased rechargeable products in exchange for new products. The Company estimates a reserve for warranty liability and records that reserve amount as a reduction of revenues and as an accrued expense on the accompanying consolidated balance sheets. The warranty claims and expense was not deemed material for the years ended December 31, 2014 and 2013.
	Income taxes
	The Company uses the asset and liability method of accounting for income taxes in accordance with ASC 740, “Income Taxes” (“ASC 740.”) Under this method, income tax expense is recognized as the amount of: (i) taxes payable or refundable for the current year and (ii) future tax consequences attributable to differences between financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the results of operations in the period that includes the enactment date. A valuation allowance is provided to reduce the deferred tax assets reported if based on the weight of available evidence it is more likely than not that some portion or all of the deferred tax assets will not be realized.
	Product Development
	The Company includes product development expenses relating to the commercialization of new products which are expensed as incurred as part of operating expenses. Product development expenses for the years ended December 31, 2014 and 2013 were approximately $312,000 and $174,000, respectively.
	Fair value measurements
	The Company applies the provisions of Accounting Standards Codification (“ASC”) 820, “Fair Value Measurements and Disclosures,” (“ASC 820”). The Company’s short term financial instruments include cash, due from merchant credit card processors, accounts receivable, accounts payable and accrued expenses, each of which approximate their fair values based upon their short term nature. The Company’s other financial instruments include notes payable obligations. The carrying value of these instruments approximate fair value, as they bear terms and conditions comparable to market, for obligations with similar terms and maturities.
	ASC 820 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 describes three levels of inputs that may be used to measure fair value: Level 1 – quoted prices in active markets for identical assets or liabilities; Level 2 – quoted prices for similar assets and liabilities in active market or inputs that are observable; and Level 3 – inputs that are unobservable.
	Stock-Based Compensation
	The Company accounts for stock-based compensation under ASC 718, “Compensation-Stock Compensation” (“ASC 718”). These standards define a fair value based method of accounting for stock-based compensation. In accordance with ASC Topic 718, the cost of stock-based compensation is measured at the grant date based on the value of the award and is recognized over the vesting period. The value of the stock-based award is determined using the Black-Scholes-Merton valuation model, whereby compensation cost is the fair value of the award as determined by the valuation model at the grant date or other measurement date. The resulting amount is charged to expense on the straight-line basis over the period in which the Company expects to receive the benefit, which is generally the vesting period. The Company considers many factors when estimating expected forfeitures, including types of awards, employee class, and historical experience.
	Derivative Instruments
	The Company accounts for free-standing derivative instruments and hybrid instruments that contain embedded derivative features in accordance with ASC Topic No. 815, “Accounting for Derivative Instruments and Hedging Activities,” (“ASC 815”) as well as related interpretations of this topic. In accordance with this topic, derivative instruments and hybrid instruments are recognized as either assets or liabilities in the balance sheet and are measured at fair values with gains or losses recognized in earnings. Embedded derivatives that are not clearly and closely related to the host contract are bifurcated and are recognized at fair value with changes in fair value recognized as either a gain or loss in earnings. The Company determines the fair value of derivative instruments and hybrid instruments based on available market data using appropriate valuation models, giving consideration to all of the rights and obligations of each instrument.
	The Company estimates fair values of derivative instruments and hybrid instruments using various techniques (and combinations thereof) that are considered to be consistent with the objective of measuring fair values. In selecting the appropriate technique, the Company considers, among other factors, the nature of the instrument, the market risks that it embodies and the expected means of settlement. For less complex instruments, such as free-standing warrants, the Company generally uses the Black-Scholes-Merton valuation model, adjusted for the effect of dilution, because it embodies all of the requisite assumptions (including trading volatility, estimated terms, dilution and risk free rates) necessary to fair value these instruments. Estimating fair values of derivative financial instruments requires the development of significant and subjective estimates that may, and are likely to, change over the duration of the instrument with related changes in internal and external market factors. In addition, option-based techniques (such as the Black-Scholes-Merton valuation model) are highly volatile and sensitive to changes in the trading market price of the Company’s common stock. Since derivative financial instruments are initially and subsequently carried at fair values, the Company’s income (loss) going forward will reflect the volatility in these estimates and assumption changes. Under ASC 815, increases in the trading price of the Company’s common stock and increases in fair value during a given financial quarter result in the application of non-cash derivative expense. Conversely, decreases in the trading price of the Company’s common stock and decreases in trading fair value during a given financial quarter result in the application of non-cash derivative income.
	Convertible Debt Instruments
	The Company accounts for convertible debt instruments when the Company has determined that the embedded conversion options should not be bifurcated from their host instruments in accordance with ASC 470-20 “Debt with Conversion and Other Options”. The Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. The Company amortizes the respective debt discount over the term of the notes, using the straight-line method, which approximates the effective interest method. The Company records, when necessary, induced conversion expense, at the time of conversion for the difference between the reduced conversion price per share and the original conversion price per share.
	Lease Accounting
	The Company evaluates each lease for classification as either a capital lease or an operating lease. If substantially all of the benefits and risks of ownership have been transferred to the Company as lessee, the Company records the lease as a capital lease at its inception. The Company performs this evaluation at the inception of the lease and when a modification is made to a lease. If the lease agreement calls for a scheduled rent increase during the lease term, the Company recognizes the lease expense on a straight-line basis over the lease term. The Company determines the straight-line rent impact of an operating lease upon inception of the lease.
	Recent Accounting Pronouncements
	The Financial Accounting Standards Board (“FASB”) has issued Accounting Standards Update (“ASU”) No. 2014-12, Compensation – Stock Compensation (Topic 718): Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period. This ASU requires that a performance target that affects vesting, and that could be achieved after the requisite service period, be treated as a performance condition. As such, the performance target should not be reflected in estimating the grant date fair value of the award. This update further clarifies that compensation cost should be recognized in the period in which it becomes probable that the performance target will be achieved and should represent the compensation cost attributable to the period(s) for which the requisite service has already been rendered. The amendments in this ASU are effective for annual periods and interim periods within those annual periods beginning after December 15, 2015. Earlier adoption is permitted. The adoption of this standard is not expected to have a material impact on the Company’s consolidated financial position and results of operations.
	The FASB has issued ASU No. 2014-09, Revenue from Contracts with Customers. This ASU supersedes the revenue recognition requirements in Accounting Standards Codification 605 - Revenue Recognition and most industry-specific guidance throughout the Codification. The standard requires that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. This ASU is effective on January 1, 2017 and should be applied retrospectively to each prior reporting period presented or retrospectively with the cumulative effect of initially applying the ASU recognized at the date of initial application. The Company is currently evaluating the potential impact, if any, the adoption of this standard will have on the Company’s consolidated financial position and results of operations.
	The FASB has issued ASU No. 2014-15, Presentation of Financial Statements-Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern. The guidance, which is effective for annual reporting periods ending after December 15, 2016, extends the responsibility for performing the going-concern assessment to management and contains guidance on how to perform a going-concern assessment and when going-concern disclosures would be required under U.S. GAAP. The Company has elected to early adopt the provisions of ASU 2014-15 in connection with the issuance of these consolidated financial statements. Information regarding the substantial doubt relating to the Company’s ability to continue as a going concern has been disclosed in Note 2.

Merger_With_Vaporin_Inc

Merger With Vaporin, Inc.	12 Months Ended
	Dec. 31, 2014
Business Combinations [Abstract]
Merger With Vaporin, Inc.	Note 4. MERGER WITH VAPORIN, INC.
	Merger with Vaporin, Inc.
	On December 17, 2014, the Company entered into the Merger Agreement with Vaporin pursuant to which Vaporin was to merge with and into the Company with Vapor being the surviving entity. The Merger closed on March 4, 2015 whereby 100% of the issued and outstanding shares of Vaporin common stock (including shares of common stock issued upon conversion of Vaporin preferred stock immediately prior to the consummation of the merger in accordance with the Merger Agreement) were converted into, and became 13,591,533 shares of the Company’s common stock such that the former Vaporin stockholders collectively hold approximately 45% of the issued and outstanding shares of the Company’s common stock following consummation of the Merger. The options and warrants to acquire Vaporin common stock that were issued and outstanding as of the effective time of the Merger, as well as 910,000 restricted stock units which were exchangeable for Vaporin common stock, were assumed by the Company in the merger and the number of shares issued under such securities were adjusted to give effect to the Per Share Merger Consideration (as defined in the Merger Agreement).
	Pursuant to the terms of the Merger Agreement, the Company completed actions to cause its board of directors immediately following the consummation of the merger to be comprised of (x) three directors chosen by the Company’s Board of Directors (at least two of whom shall be independent for purposes of the Nasdaq listing rules) and (y) two directors chosen by the Vaporin Board or Directors (at least one of whom shall be independent for purposes of the Nasdaq listing rules), each to serve for a term expiring on the earlier of his or her death, resignation, removal or the Company’s next annual meeting of stockholders and, despite the expiration of his or her term, until his or her successor has been elected and qualified or there is a decrease in the size of the Company’s Board of Directors. If at any time prior to the effective time of the merger, any such board designee becomes unable or unwilling to serve as a director of the Company following consummation of the merger, then the party that designated such individual shall designate another individual to serve in such individual’s place.
	The Merger Agreement contained customary representations and warranties of the Company and Vaporin relating to their respective businesses. The Company and Vaporin have agreed to use commercially reasonable efforts to preserve intact its business organization and that of its significant subsidiaries, as well as maintain its rights, franchises and existing relations with customers, suppliers and employees. The Merger Agreement also contains covenants by each party to furnish current information to the other party.
	The Company has also agreed that, for a period of six years following the closing date of the merger, it will indemnify, defend and hold harmless each officer and director of Vaporin and its subsidiaries against losses arising from such person’s status as an officer or director of Vaporin or any of its subsidiaries prior to the effective time of the merger. The Company has also agreed to cover such directors and officers with its existing directors’ and officers’ insurance policy or obtain a six-year “tail” policy, in each case with coverages not less advantageous as Vaporin’s existing policy, provided, however, that the Company will not be required to pay more than 200% of Vaporin’s current premium for such insurance.
	The Merger Agreement contained customary conditions that were satisfied prior to the closing of the merger, including the requirement for the Company to receive gross proceeds from a $3.5 million equity offering disclosed in Note 13. Additionally, the Company must have received commitments from certain third parties for financing of up to $25 million to be used for the construction of retail stores and which is contingent on the achievement of certain performance metrics by the Company.
	The fair value of the purchase consideration issued to the sellers of Vaporin was allocated to fair value of the net tangible assets acquired, with the resulting excess allocated to separately identifiable intangibles, and the remainder recorded as goodwill. Goodwill recognized from the transactions mainly represented the expected operational synergies upon acquisition of the combined entity and intangibles not qualifying for separate recognition. Goodwill is not expected to be deductible for income tax purposes in the tax jurisdiction of the acquired business.
	The Company has not completed its evaluation of the purchase price allocation as it is currently conducting a thorough analysis to identify the intangible assets acquired, including whether or not any goodwill is to be recorded, in the Merger and determine the proper allocation of the fair value of such assets with the assistance of a third-party appraiser.
	The following table presents the unaudited pro-forma financial results, as if the acquisition of Vaporin had been completed as of January 1, 2013 and 2014:
		For the Years Ended
		December 31,
		2014			2013
	Revenues	$	20,253,052		$	28,259,309
	Net (loss) income	$	(19,595,702	)	$	415,316
	Loss per share - basic and diluted	$	(0.59	)	$	0.01
	The unaudited pro-forma results of operations are presented for information purposes only. The unaudited pro-forma results of operations are not intended to present actual results that would have been attained had the acquisition been completed as of January 1, 2013 or to project potential operating results as of any future date or for any future periods.
	The Joint Venture
	On December 17, 2014, the Company and Vaporin agreed to enter into the Joint Venture through Emagine, a Delaware limited liability company of which the Company and Vaporin are 50% members. The Operating Agreement provides that Vaporin will serve as the initial manager of Emagine and will manage the day-to-day operations of Emagine, subject to certain customary limitations on managerial actions that require the unanimous consent of the Company and Vaporin, including but not limited to making or guaranteeing loans, distributing cash or other property to the members of Emagine, entering into affiliate transactions, amending or modifying limited liability company organizational documents, and redeeming or repurchasing membership interests from any of the members.
	The purpose of the Joint Venture was to obtain and build-out retail stores for the sale of the Company and Vaporin’s products under the “Emagine Vapor” name or “The Vape Store, Inc.” name or other brands of the respective parties. The parties originally planned to finance the retail stores through third party loan financing secured by a blanket lien on the assets of Emagine. In connection with the Joint Venture, Emagine entered into a Secured Line of Credit Agreement, pursuant to which certain third parties have agreed to provide debt financing of up to $3 million to Emagine to finance the Joint Venture. The Company has accounted for the joint venture under the equity method of accounting for investments. For the year ended December 31, 2014, the operations of the joint-venture were immaterial.
	In connection with the completion of the Merger on March 4, 2015, Emagine became a wholly-owned subsidiary of the Company.

Property_and_Equipment

Property and Equipment	12 Months Ended
	Dec. 31, 2014
Property, Plant and Equipment [Abstract]
Property and Equipment	Note 5. PROPERTY AND EQUIPMENT
	Property and equipment consists of the following:
		December 31,
		2014			2013
	Computer hardware	$	389,373		$	12,471
	Furniture and fixtures		347,612			19,821
	Warehouse fixtures		7,564			7,564
	Warehouse equipment		16,708			16,708
	Leasehold improvements		35,076			-
			796,333			56,564
	Less: accumulated depreciation and amortization		(84,314	)		(27,879	)
		$	712,019		$	28,685
	During the year ended December 31, 2014 and 2013, the Company incurred $56,435 and $11,284, respectively, of depreciation expense.

Notes_Payable

Notes Payable	12 Months Ended
	Dec. 31, 2014
Debt Disclosure [Abstract]
Notes Payable	Note 6. NOTES PAYABLE
	$1,250,000 Senior Convertible Notes Payable to Related Parties
	On November 14, 2014, the Company entered into securities purchase agreements with certain accredited investors who are also stockholders of Vaporin providing for the sale of $1,250,000 in aggregate principal amount of the Company’s senior convertible notes (the “$1,250,000 Senior Convertible Notes”) and common stock purchase warrants to purchase up to an aggregate of 1,136,364 shares of the Company’s common stock, $0.001 par value per share with an exercise price of $2.00 per share. The $1,250,000 Senior Convertible Notes accrue interest on the outstanding principal at an annual rate of 7% per annum. The principal and accrued interest on the Notes are due and payable on November 14, 2015, the maturity date of the Notes. The terms of the $1,250,000 Senior Convertible Notes included customary anti-dilution protection and also included “piggy-back” registration rights with respect to the shares of common stock underlying the $1,250,000 Senior Convertible Notes and warrants. The terms of the Notes provide that the Company may prepay the outstanding principal amount of the Notes, in whole or in part, by paying to the holders thereof an amount in cash equal to 115% of the principal amount to be redeemed, together with accrued but unpaid interest thereon and any and all other sums due, accrued or payable to such holders through the date of such redemption payment. In connection with the completion of the securities purchase agreement for the $1,250,000 Senior Convertible Notes, the Company incurred financing costs of $139,667, which are being amortized on a straight-line basis, which approximates the interest rate method, over the one-year maturity period of the $1,250,000 Senior Convertible Notes. The Company incurred $17,458 in amortization expense of the deferred financing costs during the year ended December 31, 2014.
	The Notes are convertible into shares of the Company’s Common Stock at any time, in whole or in part, at the option of the holder thereof at a conversion price of $1.10 per share (the “Conversion Price”). The Conversion Price is subject to customary adjustment upon the occurrence of certain events, including but not limited to stock dividends, stock splits, subsequent rights offerings of the Company, pro rata distributions of the Company, and in connection with a “Fundamental Transaction” (as such term is defined in the securities purchase agreement, which includes, without limitation, mergers, consolidations, a sale of all or substantially all of the assets of the Company, transactions effecting a change in control of the Company and other similar transactions).
	In connection with the sale and issuance of the $1,250,000 Senior Convertible Notes, the Company also issued warrants to acquire an aggregate of 1,136,364 shares of the Company’s common stock. The Warrants are exercisable after 180 days from the date of issuance, or May 14, 2015, until the fifth anniversary of such date of issuance at an exercise price of $2.00 per share (subject to certain customary adjustments upon the occurrence of certain events, including but not limited to stock dividends, stock splits, subsequent rights offerings of the Company, pro rata distributions of the Company, and in connection with a Fundamental Transaction. Palladium Capital Advisors, LLC acted as the exclusive placement agent for the $1,250,000 Senior Convertible Notes and, as compensation therefor, the Company paid Palladium Capital Advisors, LLC a placement agent fee of $62,500, included as part of financing fees described above, and issued to them a common stock warrant to purchase up to 56,818 shares of our common stock at an initial exercise price of $2.00 per share. The warrant is immediately exercisable and expires on November 14, 2019. The exercise price and number of shares of common stock issuable under the warrant are subject to customary anti-dilutive adjustments for stock splits, stock dividends, recapitalizations and similar transactions. At any time the warrant may be exercised by means of a “cashless exercise” and the Company will not receive any proceeds at such time.
	On the date of the issuance of the $1,250,000 Senior Convertible Notes, the Company recorded a debt discount of $1,250,000, of which $701,250 was allocated on a relative fair value basis to the warrants issued and the remaining $548,750 was allocated on a relative fair value basis to the conversion feature embedded within the $1,250,000 Senior Convertible Notes. The debt discount will be amortized using the effective interest method over the life of the $1,250,000 Senior Convertible Note, as applicable, or until such time that the $1,250,000 Senior Convertible Notes are converted, in full or in part, into shares of common stock of the Company with any unamortized debt discount continuing to be amortized in the event of any partial conversion thereof and any unamortized debt discount being expensed at such time of full conversion thereof. During the year ended December 31, 2014, the Company recorded an aggregate $156,250 in non-cash interest expense related to the amortization of the debt discount, which is included in interest expense in the accompanying consolidated statement of operations.
	$300,000 Senior Convertible Notes Payable to Related Parties
	On June 19, 2012, the Company entered into securities purchase agreements with Kevin Frija, its former Chief Executive Officer, Harlan Press, its former Chief Financial Officer, and Doron Ziv, a then greater than 10% stockholder of the Company, pursuant to which Messrs. Frija, Press and Ziv purchased from the Company (i) $300,000 aggregate principal amount of the Company’s senior convertible notes (the “$300,000 Senior Convertible Notes”) and (ii) common stock purchase warrants to purchase up to an aggregate of 9,303 shares of the Company’s common stock.
	The Company incurred interest expense of $48,674 during 2013 on the $300,000 Senior Convertible Notes until they were converted in full into 281,691 shares of the Company’s common stock and fully extinguished in conjunction with completion of the Private Placement (as defined in Note 9), on October 29, 2013.
	$50,000 Senior Convertible Notes Payable to Related Parties
	On September 28, 2012, the Company entered into a securities purchase agreement with Kevin Frija, its former Chief Executive Officer, pursuant to which Mr. Frija purchased from the Company (i) a $50,000 principal amount senior convertible note of the Company (the “$50,000 Senior Convertible Note”) and (ii) common stock purchase warrants to purchase up to an aggregate of 1,374 shares of the Company’s common stock.
	The Company incurred interest expense of $8,113 during 2013 on the $50,000 Senior Convertible Notes until they were converted in full into 41,667 shares of the Company’s common stock and fully extinguished in conjunction with completion of the Private Placement (as defined in Note 9), on October 29, 2013. During the year ended December 31, 2013, the Company recorded $3,530 in amortization expense related to the debt discount, which is included in interest expense in the accompanying consolidated statements of operations.
	$350,000 Senior Convertible Notes Payable to Related Parties
	On July 9, 2013, the Company entered into securities purchase agreements with Ralph Frija, the father of the Company’s former Chief Executive Officer Kevin Frija and a less than 5% stockholder of the Company, Philip Holman, the father of the Company’s Chief Executive Officer Jeffrey Holman and a less than 5% stockholder of the Company, and Angela Vaccaro, the Company’s Controller, pursuant to which Messrs. Frija and Holman and Ms. Vaccaro (each, a “Purchaser”) purchased from the Company (i) $350,000 aggregate principal amount of the Company’s senior convertible notes (the “$350,000 Senior Convertible Notes”) and (ii) common stock purchase warrants to purchase up to an aggregate of 3,373 shares of the Company’s common stock (the “Warrants”) allocable among such Purchasers as follows:
		●	Ralph Frija purchased a Convertible Note in the principal amount of $200,000 and a Warrant to purchase up to 1,927 shares of the Company’s common stock (which number of shares represents the quotient obtained by dividing (x) $10,000 (5% of the $200,000 principal amount of the Convertible Note) by (y) $5.19 (the 30-day weighted average closing price per share of the Company’s common stock, as reported on the OTC Bulletin Board, preceding July 9, 2013));
		●	Philip Holman purchased a Convertible Note in the principal amount of $100,000 and a Warrant to purchase up to 964 shares of the Company’s common stock (which number of shares represents the quotient obtained by dividing (x) $5,000 (5% of the $100,000 principal amount of the Convertible Note) by (y) $5.19 (the 30-day weighted average closing price per share of the Company’s common stock, as reported on the OTC Bulletin Board, preceding July 9, 2013)); and
		●	Ms. Vaccaro purchased a Convertible Note in the principal amount of $50,000 and a Warrant to purchase up to 482 shares of the Company’s common stock (which number of shares represents the quotient obtained by dividing (x) $2,500 (5% of the $50,000 principal amount of the Convertible Note) by (y) $5.19 (the 30-day weighted average closing price per share of the Company’s common stock, as reported on the OTC Bulletin Board, preceding July 9, 2013)).
	The Convertible Notes issued on July 9, 2013 bear interest at 18% per annum, provide for cash interest payments on a monthly basis, mature on July 8, 2016, are redeemable at the option of the holders at any time after July 8, 2014, subject to certain limitations, are convertible into shares of the Company’s common stock at the option of the holders at an initial conversion price of $5.71 per share (which represents 110% of the 30-day weighted average closing price per share of the Company’s common stock, as reported on the OTC Bulletin Board, preceding July, 9, 2013) subject to certain anti-dilution protection and are senior unsecured obligations of the Company.
	The Company incurred interest expense of $16,126 during 2013 on the $350,000 Senior Convertible Notes. In conjunction with completion of the Private Placement (as defined in Note 9), on October 29, 2013, the conversion price was reduced to $3.00 per share inducing the holders of $350,000 Senior Convertible Notes to fully convert all of these senior convertible notes into 116,668 shares of our common stock, whereupon all of these senior convertible notes were fully extinguished and cease to be outstanding. During the year ended December 31, 2013, the Company recorded $246,375 in induced conversion expense related to the reduction in the conversion price for the $350,000 Senior Convertible Notes. The induced conversion expense is included in other expense in the accompanying consolidated statements of operations.
	The Company recorded $4,550 as debt discount on the principal amount of the $350,000 Senior Convertible Notes issued on July 9, 2013 due to the valuation of the Warrants issued in conjunction therewith. Additionally, as a result of issuing the Warrants with the $350,000 Senior Convertible Notes, a beneficial conversion option was recorded as a debt discount reflecting the incremental conversion option intrinsic value benefit of $3,937, at the time of issuance provided to the holders of the Notes. The debt discounts applicable to the $350,000 Senior Convertible Notes was amortized, using the straight-line method, over the life of the $350,000 Senior Convertible Notes, until October 29, 2013 when the $350,000 Senior Convertible Notes were converted in full into shares of common stock of the Company. The remaining unamortized debt discounts was expensed at the time of the conversion. During the year ended December 31, 2013, the Company recorded $4,550 and $3,937 in amortization expense related to the debt discounts and the beneficial conversion option, respectively. The amortization expense related to the debt discounts and the beneficial conversion option is included in interest expense in the accompanying consolidated statements of operations.
	The Warrants issued on July 9, 2013 are exercisable at initial exercise prices of $5.71 per share (which represents 110% of the 30-day weighted average closing price per share of the Company’s common stock, as reported on the OTC Bulletin Board, preceding July 9, 2013) subject to certain anti-dilution protection and may be exercised at the option of the holders for cash or on a cashless basis until July 8, 2018.
	$75,000 Senior Convertible Notes Payable to Related Parties
	On July 11, 2013, the Company and Ms. Vaccaro entered into another Securities Purchase Agreement pursuant to which she purchased (i) a Convertible Note in the principal amount of $75,000 (the “$75,000 Senior Convertible Note”) and (ii) a Warrant to purchase up to 718 shares of the Company’s common stock (which number of shares represents the quotient obtained by dividing (x) $3,750 (5% of the $75,000 principal amount of the Convertible Note) by (y) $5.227 (the 30-day weighted average closing price per share of the Company’s common stock, as reported on the OTC Bulletin Board, preceding July 11, 2013)).
	The Convertible Note issued on July 11, 2013 is the same as the Convertible Notes issued on July 9, 2013 except that it matures on July 10, 2016, it is redeemable on July 10, 2014 and its initial conversion price is $5.75 per share. The Warrant issued on July 11, 2013 is the same as the Warrants issued on July 9, 2013 except that its initial exercise price is $5.75 per share and it is exercisable until July 10, 2018.
	The Company incurred interest expense of $3,957 during 2013 on the $75,000 Senior Convertible Notes. In conjunction with completion of the Private Placement (as defined in Note 9), on October 29, 2013, the conversion price was reduced to $3.00 per share inducing the holder of the $75,000 Senior Convertible Note to fully convert all of these senior convertible notes into 25,000 shares of our common stock, whereupon all of these senior convertible notes were fully extinguished and cease to be outstanding. During the year ended December 31, 2013, the Company recorded $53,202 in induced conversion expense related to the reduction in the conversion price for the $75,000 Senior Convertible Note. The induced conversion expense is included in other expense in the accompanying consolidated statements of operations.
	The Company recorded $825 as debt discount on the principal amount of the $75,000 Senior Convertible Note issued on July 11, 2013 due to the valuation of the Warrant issued in conjunction therewith. The debt discount applicable to the $75,000 Senior Convertible Note was amortized, using the straight-line method, over the life of the $75,000 Senior Convertible Note, until October 29, 2013 when the $75,000 Senior Convertible Note was converted in full into shares of common stock of the Company. The remaining unamortized debt discounts was expensed at the time of the conversion. During the year ended December 31, 2013, the Company recorded $825 in amortization expense related to the debt discount, and is included in interest expense in the accompanying consolidated statements of operations.
	The $300,000 Senior Convertible Notes, as amended, the $50,000 Senior Convertible Note, as amended, the $350,000 Senior Convertible Notes, and the $75,000 Senior Convertible Note did not restrict the Company’s ability to incur future indebtedness.
	$500,000 Senior Convertible Note Payable to Stockholder
	On July 9, 2012, the Company borrowed $500,000 from Ralph Frija, the father of the Company’s former Chief Executive Officer Kevin Frija and a less than 5% stockholder of the Company, pursuant to a senior note (the “Senior Note”). The Senior Note, as amended (as described below), bears interest at 24% per annum, provides for cash principal and interest payments on a monthly basis, is a senior unsecured obligation of the Company, matures on April 22, 2016, is convertible into shares of the Company’s common stock at the option of the holder at an initial conversion price of $2.577 per share (which represents 110% of the 30-day weighted average closing price per share of the Company’s common stock, as reported on the OTC Bulletin Board, preceding April 30, 2013) subject to certain anti-dilution protection and is a senior unsecured obligation of the Company.
	Initially, this Senior Note provided for only cash interest payments on a monthly basis, matured at the discretion of the Company on the earlier of (x) the date on which the Company consummated a single or series of related financings from which it received net proceeds in excess of 125% of the initial principal amount of the Senior Note or (y) January 8, 2013 and was not convertible at the option of the holder into shares of the Company’s common stock. On November 13, 2012, the Company and the above named holder of the $500,000 Senior Note amended the Note to extend its maturity date for payment from January 8, 2013 to January 8, 2014. On April 30, 2013, the Company and the above named holder of the Senior Note further amended the Note to provide for cash principal and interest payments on a weekly basis, extend the maturity date for payment to April 22, 2016 and make the Note convertible into shares of the Company’s common stock at the option of the holder at an initial conversion price of $2.577 per share (which represents 110% of the 30-day weighted average closing price per share of the Company’s common stock, as reported on the OTC Bulletin Board, preceding April 30, 2013) subject to certain anti-dilution protection.
	The Company incurred interest expense of $93,267 during 2013 on the $50,000 Senior Convertible Notes until they were converted in full into 166,662 shares of the Company’s common stock and fully extinguished in conjunction with completion of the Private Placement (as defined in Note 9), on October 29, 2013.
	$500,000 Senior Convertible Note Payable
	On January 29, 2013, the Company entered into a securities purchase agreement (the “Securities Purchase Agreement”) with Robert John Sali, pursuant to which Mr. Sali purchased from the Company (i) a $500,000 principal amount senior convertible note of the Company (the “2013 Convertible Note”) and (ii) common stock purchase warrants to purchase up to an aggregate of 8,142 shares of the Company’s common stock (the “Warrant”) (which number of shares represents the quotient obtained by dividing (x) $25,000 (5% of the $500,000 principal amount of the 2013 Convertible Note) by (y) $3.07 (the 30-day weighted average closing price per share of the Company’s common stock, as reported on the OTC Bulletin Board, preceding January 29, 2013)). The Company generated aggregate proceeds of $500,000 from the sale of these securities pursuant to the Securities Purchase Agreement.
	The 2013 Convertible Note bears interest at 18% per annum, provides for cash interest payments on a monthly basis, matures on January 28, 2016, is redeemable at the option of the holder at any time after January 28, 2014 subject to certain limitations, is convertible into shares of the Company’s common stock at the option of the holder at an initial conversion price of $3.3775 per share (which represents 110% of the 30-day weighted average closing price per share of the Company’s common stock, as reported on the OTC Bulletin Board, preceding January 29, 2013) subject to certain anti-dilution protection and is a senior unsecured obligation of the Company. The 2013 Convertible Note does not restrict the Company’s ability to incur future indebtedness.
	The Company incurred interest expense of $66,329 during 2013 on the $50,000 Senior Convertible Notes until they were converted in full into 148,039 shares of the Company’s common stock and fully extinguished in conjunction with completion of the Private Placement (as defined in Note 9), on October 29, 2013.
	The Warrant is exercisable at initial exercise price of $3.3775 per share (which represents 110% of the 30-day weighted average closing price per share of the Company’s common stock, as reported on the OTC Bulletin Board, preceding January 29, 2013) subject to certain anti-dilution protection and may be exercised at the option of the holder for cash or on a cashless basis until January 28, 2018.
	The Company recorded $10,131 as debt discount on the principal amount of the 2013 Senior Convertible Note issued on January 29, 2013 due to the valuation of the Warrant issued in conjunction therewith. Additionally, as a result of issuing the Warrant with the 2013 Senior Convertible Note, a beneficial conversion option was recorded as a debt discount reflecting the incremental conversion option intrinsic value benefit of $79,527, at the time of issuance provided to the holder of the Note. The debt discounts applicable to the 2013 Convertible Note was amortized, using the straight-line method, over the life of the 2013 Convertible Note, until October 29, 2013 when the 2013 Convertible Note was converted in full into shares of common stock of the Company. The remaining unamortized debt discounts was expensed at the time of the conversion. During the year ended December 31, 2013, the Company recorded $10,131 and $79,527 in amortization expense related to the debt discounts and the beneficial conversion option, respectively. The amortization expense related to the debt discounts and the beneficial conversion option is included in interest expense in the accompanying consolidated statements of operations.

Factoring_Facility_and_Term_Lo

Factoring Facility and Term Loan Payable	12 Months Ended
	Dec. 31, 2014
Factoring Facility And Term Loan Payable
Factoring Facility and Term Loan Payable	Note 7. FACTORING FACILITY AND TERM LOAN PAYABLE
	Factoring Facility
	On August 8, 2013, the Company and Smoke entered into an accounts receivable factoring facility (the “Factoring Facility”) with Entrepreneur Growth Capital, LLC (the “Lender”) pursuant to an Invoice Purchase and Sale Agreement, dated August 8, 2013, by and among them (the “Factoring Agreement”).
	The Factoring Facility has an initial term of one year and automatically renews from month to month thereafter subject to the Company terminating it earlier upon at least 15 business days’ advance written notice provided that all obligations are paid (including a termination fee, if applicable, as specified in the Factoring Agreement). The Factoring Facility is secured by a security interest in substantially all of the Company’s assets. Under the terms of the Factoring Agreement, the Lender may, at its sole discretion, purchase certain of the Company’s eligible accounts receivable. Upon any acquisition of an account receivable, the Lender will advance to the Company up to 50% of the face amount of the account receivable. Each account receivable purchased by the Lender will be subject to a factoring fee of 1% of the gross face amount of such purchased account for each 30 day period (or part thereof) the purchased account remains unpaid. The Lender will generally have full recourse against the Company in the event of nonpayment of any such purchased account.
	The Factoring Agreement contains covenants and provisions relating to events of default that are customary for agreements of this type. The failure to satisfy covenants under the Factoring Agreement or the occurrence of other specified events that constitute an event of default could result in the termination of the Factoring Facility and/or the acceleration of the repayment obligations of the Company.
	During the year ended December 31, 2013 gross borrowings under the Factoring Facility were $407,888, all of which were repaid as of September 30, 2013. There were no borrowings during the year ended December 31, 2014.
	2013 Term Loan
	On August 16, 2013, the Company and Smoke entered into a $750,000 term loan (the “2013 Term Loan”) with the Lender pursuant to a Credit Card Receivables Advance Agreement, dated August 16, 2013, by and among them (the “Term Agreement”).
	The Term Loan matured on August 15, 2014, was payable from the Company’s and Smoke’s merchant credit card receivables at the annual rate of 16% subject to the Lender retaining a daily fixed amount of $3,346 from the daily collection of the merchant credit card receivables and is secured by a security interest in substantially all of the Company’s assets. The Company used the proceeds of the Term Loan for general working capital purposes.
	At December 31, 2013 the Company had $478,847 of borrowings outstanding under the 2013 Term Loan. During the year ended December 31, 2014 and 2013, the Company recorded $76,617 and $44,769, respectively, in interest expense for the 2013 Term Loan and this amount is included in interest expense in the accompanying consolidated statements of operations. The 2013 Term Loan was repaid in full during the year ended December 31, 2014.
	2014 Term Loan
	On September 23, 2014, the Company and Smoke entered into a $1,000,000 term loan (the “2014 Term Loan”) with the Lender pursuant to a secured promissory note entered into by the Company and Smoke in favor of the Lender (the “Secured Note”). Under the Secured Note, the 2014 Term Loan bears interest at 14% per annum and is secured by a security interest in substantially all of the Company’s assets. Under the Secured Note, the principal amount of the 2014 Term Loan is payable in twelve (12) successive monthly installments of $83,333 with the last payment due in September 2015. Interest on the 2014 Term Loan is payable in arrears. The Company used the proceeds of the 2014 Term Loan for general working capital purposes.
	The Term Agreement contains covenants that are customary for agreements of this type. The failure to satisfy covenants under the Term Agreement or the occurrence of other specified events that constitute an event of default could result in the termination of the Term Agreement (as well as the Factoring Agreement) and/or the acceleration of the repayment of the Term Loan and the other obligations of the Company (including the Factoring Facility). The Term Agreement contains provisions relating to events of default that are customary for agreements of this type.
	At December 31, 2014, the Company had $750,000 of borrowings outstanding under the 2014 Term Loan. During the year ended December 31, 2014, the Company recorded $24,086 in interest expense for the 2014 Term Loan and this amount is included in interest expense in the accompanying consolidated statements of operations.
	The Company’s Chief Executive Officer and Former Chief Financial Officer have personally guaranteed performance of certain of the Company’s obligations under the Factoring Agreement and the Term Agreement. In consideration of the Company’s Former Chief Financial Officer providing the personal guarantee, the Company has agreed to amend his employment agreement as described in Note 9.

Capital_Lease_Obligations

Capital Lease Obligations	12 Months Ended
	Dec. 31, 2014
Leases [Abstract]
Capital Lease Obligations	Note 8. CAPITAL LEASE OBLIGATIONS
	On October 1, 2014, the Company entered into a capital lease obligation in connection with the acquisition of equipment for its retail locations in the principal amount of $179,359. Annual interest on the capital lease obligation is 15.8% and borrowings are to be repaid over 36 months maturing on October 17, 2017. During the year ended December 31, 2014, the Company incurred interest expense associated with the capital lease obligation of $4,679. Depreciation expense incurred during the year ended December 31, 2014 for equipment held under capital lease obligations was $9,964. The net book value of equipment held under capital lease obligations at December 31, 2014 is $169,395.
	Future minimum lease payments under non-cancelable capital leases that have initial or remaining terms in excess of one year at December 31, 2014 are due as follows:
		Capital
		Lease
	2015	$	75,485
	2016		75,485
	2017		62,904
	Total		213,874
	Amounts representing interest payments		(42,416	)
	Present value of future minimum payments		171,458
	Current portion of capital lease obligations		(52,015	)
	Capital lease obligations, long term	$	119,443

Stockholders_Equity

Stockholders' Equity	12 Months Ended
	Dec. 31, 2014
STOCKHOLDERS' EQUITY:
Stockholders' Equity	Note 9. STOCKHOLDERS’ EQUITY
	Preferred Stock
	The Company’s amended and restated articles of incorporation authorizes the Company’s Board of Directors to issue up to 1,000,000 shares of “blank check” preferred stock, having a $0.001 par value, in one or more series without stockholder approval. Each such series of preferred stock may have such number of shares, designations, preferences, voting powers, qualifications, and special or relative rights or privileges as determined by the Company’s Board of Directors. At December 31, 2014 and 2013, no shares of preferred stock were issued or outstanding.
	Common Stock
	The Company’s amended and restated articles of incorporation authorizes the Company’s Board of Directors to issue up to 50,000,000 shares of common stock having a par value of $0.001 per share. Each share entitles the holder to one vote.
	Common Stock Issued for Services
	On March 15 and June 15, 2013, the Company issued a total of 20,000 shares of common stock, pursuant to a consultancy agreement dated March 4, 2013. The Company terminated this consultancy agreement effective June 2013. Prior to termination of the agreement, the Company had agreed to issue on a quarterly basis common stock as compensation for services provided thereunder. The Company determined that the fair value of the common stock issued was more readily determinable than the fair value of the services provided. Accordingly, the Company recorded the fair market value of the stock as compensation expense. The Company valued the shares issued on March 15 and June 15, 2013 shares at $29,500 and $57,500, respectively, based on closing price per share of the Company’s common stock, as reported on the OTC Bulletin Board, on March 15 and June 15, 2013, respectively. During the year ended December 31, 2013, the Company recognized stock-based compensation expense in the amount of $87,000, which is included as part of selling, general and administrative expense in the accompanying consolidated statements of operations.
	On February 3, 2014, the Company entered into a consulting agreement (the “Consulting Agreement”) with Knight Global Services, LLC (“Knight Global”) pursuant to which the Company retained Knight Global to assist the Company with increasing awareness of its electronic cigarette brands as well as assisting the Company to expand and diversify its relationships with large retailers and national chains. Knight Global is a wholly owned subsidiary of Knight Global, LLC of which Ryan Kavanaugh is an investor and principal. Effective March 5, 2014, the Board of Directors of the Company elected Mr. Kavanaugh as a member of the Board of Directors in accordance with the Consulting Agreement. Knight Global serves as the family office for Mr. Kavanaugh. Mr. Kavanaugh is the Founder and Chief Executive Officer of Relativity, a next-generation media company engaged in multiple aspects of entertainment, including film production; financing and distribution; television; sports management; music publishing; and digital media.
	Under the terms of the Consulting Agreement, the Company has issued to Mr. Kavanaugh 400,000 shares of its common stock, of which 50,000 shares vested immediately upon execution of the Consulting Agreement, 50,000 shares vested on May 3, 2014, 50,000 shares vested on August 3, 2014, 50,000 shares vested on November 3, 2014 and 50,000 shares will vest in installments of 50,000 shares each quarterly period beginning on the 90th day following November 3, 2014 and each ensuing quarterly period thereafter so long as the Consulting Agreement has not been terminated and during each quarterly period Knight Global has presented the Company with a minimum of six (6) bona fide opportunities for activities specified in the Consulting Agreement that are intended to increase awareness of the Company’s electronic cigarettes. In addition, during the term of the Consulting Agreement, which is 2 years, and during an 18-month post-termination period, the Company has agreed to pay Knight Global commissions payable in cash equal to 6% of “net sales” (as defined in the Consulting Agreement) of its products to retailers introduced by Knight Global and to retailers with which the Company has existing relationships and with which Knight Global is able, based on its verifiable efforts, to increase net sales of the Company’s products. No commissions were paid under the consulting agreement during the year ended December 31, 2014.
	The grant date fair value of the common shares issued on February 3, 2014 was $3,080,000 based on closing price per share of the Company’s common stock, as reported on the OTC Bulletin Board, on February 3, 2014. During the year ended December 31, 2014, the Company recognized stock-based compensation expense relating to the Consulting Agreement, in the amount of $1,602,933, which is included as part of selling, general and administrative expense in the accompanying consolidated statements of operations.
	On January 24, 2015, the Company and Knight Global mutually agreed to terminate the Consulting Agreement as it was in the best interests of both parties to do so. As a result of such termination, the Company issued 50,000 shares of its common stock to Knight Global pursuant to the early termination provisions of the Consulting Agreement. The Company will incur $322,067 in connection with this final issuance during the first quarter of 2015. In addition, on January 24, 2015, the Company received notice from Ryan Kavanaugh, a director of the Company that he had resigned from the Company’s board of directors, effective immediately.
	Private Placement of Common Stock
	On October 22, 2013, the Company entered into a purchase agreement (the “Purchase Agreement”) with various institutional and individual accredited investors and certain of its officers and directors to raise gross proceeds of $10 million in a private placement of 3,333,338 shares of its common stock at a per share price of $3.00 (the “Private Placement”). On October 29, 2013, the Company completed the Private Placement. The Company received net proceeds from the Private Placement of approximately $9.0 million, after paying placement agent fees and estimated offering expenses, which the Company used to fund its growth initiatives and for working capital purposes. Of the approximate $1 million in offering costs, approximately $110,000 were incurred during the year ended December 31, 2014.
	Pursuant to the Purchase Agreement, concomitantly with completion of the Private Placement, the Company entered into a registration rights agreement with the investors (other than its participating officers and directors), pursuant to which the Company filed with the SEC an initial registration statement to register for resale the 3,216,171 shares of the Company’s common stock purchased by the investors (other than the Company’s participating officers and directors). The initial registration statement was declared effective by the SEC on January 27, 2014. On March 5, 2014, the Company filed a post-effective amendment to the initial registration statement. The post-effective amendment to the initial registration statement was declared effective by the SEC on March 11, 2014. On June 20, 2014, the Company filed a second post-effective amendment to the initial registration statement. The second post-effective amendment to the initial registration statement was declared effective by the SEC on June 27, 2014. If the second post-effective amendment to the initial registration statement after being declared effective by the SEC is not effective for resales for more than 20 consecutive days or more than 45 days in any 12 month period during the registration period (i.e., the earlier of the date on which the shares have been sold or are eligible for sale under SEC Rule 144 without restriction), the Company is required to pay the investors (other than the Company’s participating officers and directors) liquidated damages in cash equal to 1.5% of the aggregate purchase price paid by the investors for the shares for every 30 days or portion thereof until the default is cured. These cash payments could be as much as $81,489 for every 30 days.
	Under the terms of the Purchase Agreement, the Company:
		●	Amended its existing equity incentive plan on November 20, 2013 to reduce the number of shares of its common stock reserved and available for issuance under the plan to 1.8 million from 8 million.
		●	Effectuated a reverse stock split of its common stock at a ratio of 1-for-5, which became effective in the marketplace at the opening of business December 27, 2013 (as disclosed in Note 1 above).
		●	Reincorporated to the State of Delaware effective on December 31, 2013 (as disclosed in Note 1).
		●	Reconstituted its board of directors effective April 25, 2014 so that the board of directors consists of five members, a majority of whom each qualify as an “independent director” as defined in NASDAQ Marketplace Rule 5605(a)(2) and the related NASDAQ interpretative guidance; and
		●	Listed its common stock on The NASDAQ Capital Market effective May 30, 2014.
	In conjunction with completion of the Private Placement, on October 29, 2013, the holders of the Company’s approximately $1.7 million of outstanding senior convertible notes, some of whom were officers and directors of the Company, converted in full all of these senior convertible notes into approximately 780,000 shares of the Company’s common stock, whereupon all of these senior convertible notes were fully extinguished and cease to be outstanding. See Note 6.
	All of the warrants issued in conjunction with the convertible notes described in Note 6 and the Private Placement were evaluated in accordance with ASC 815 and were determined to be equity instruments. The Company estimated the fair value of these Warrants using the Black-Scholes-Merton valuation model. The significant assumptions which the Company used to measure their respective fair values included stock prices ranging from $1.00 to $3.50 per share, expected terms of 5 years, volatility ranging from 30.3% to 51.4%, risk free interest rates ranging from 0.71% to 0.90%, and a dividend yield of 0.0%.
	Warrants
	A summary of warrant activity for the years ended December 31, 2014 and 2013 is presented below:
			Number of			Weighted-			Weighted-		Aggregate
			Warrants			Average			Average		Intrinsic
						Exercise Price			Contractual		Value
									Term
	Outstanding at January 1, 2013			10,677		$	1.08
	Warrants granted			205,203			3.34
	Warrants exercised			—			—
	Warrants forfeited or expired			—			—
	Outstanding at December 31, 2013			215,880		$	3.23
	Warrants granted			1,193,181			2
	Warrants exercised			(192,970	)		3.3
	Warrants forfeited or expired			—			—
	Outstanding at December 31, 2014			1,216,091		$	2.01			5	$	—
	Exercisable at December 31, 2014			215,620		$	3.23			5	$	—
	During the year ended December 31, 2014, 192,970 warrants were exercised in a cashless manner into 142,383 shares of common stock.
	Equity Incentive Plan
	There are 1,800,000 shares of common stock reserved for issuance under the Company’s Equity Incentive Plan (after giving effect to the reduction of the number of shares reserved and available for issuance thereunder and the 1-for-5 reverse stock split, each as implemented in accordance with the Purchase Agreement governing the Private Placement), which was duly adopted by the stockholders on November 24, 2009. The Plan provides for the granting of incentive stock options to employees, the granting of non-qualified stock options to employees, non-employee directors and consultants, and the granting of restricted stock to employees, non-employee directors and consultants in connection with their retention and/or continued employment by the Company. Options issued under the Plan generally have a ten-year term and generally become exercisable over a four-year period. Shares subject to awards that expire unexercised or are forfeited or terminated will again become available for issuance under the Plan. No participant in the Equity Incentive Plan can receive option grants and/or restricted shares for more than 20% of the total shares subject to the Plan.
	Stock-Based Compensation
	On March 6, 2014, the Board granted to Ryan Kavanaugh a non-qualified Director’s stock option award under the Company’s Equity Incentive Plan to purchase up to 60,000 shares of the Company’s common stock at an exercise price per share equal to $8.30 (the closing share price of the Company’s common stock as reported on the OTC Bulletin Board at the close of trading on the grant date). On April 25, 2014, the Board granted to each of the three (3) other New Directors a non-qualified stock option award under the Company’s Equity Incentive Plan to purchase up to 60,000 shares of the Company’s common stock at an exercise price per share equal to $6.48 (the closing share price of the Company’s common stock as reported on the OTC Bulletin Board at the close of trading on the grant date). Each of the New Director’s stock options expire on the fifth anniversary of the grant date, vest in equal annual installments over a three-year period from the grant date subject to he/she serving as a member of the Board on each such vesting date and is to be evidenced by a non-qualified stock option agreement customarily utilized under the Equity Incentive Plan. The weighted average grant date fair value of the March 6 and April 25, 2014 awards were $149,160 and $315,720, respectively.
	In addition, during the year ended December 31, 2014, the Company issued non-qualified stock option awards under the Company’s Equity Incentive Plan to purchase up to 12,000 shares of the Company’s common stock at an exercise price equal to $8.30 (the closing share price of the Company’s common stock as reported on the OTC Bulletin Board at the close of trading on the grant date). The options vest in 3 annual installments and had an aggregate grant date fair value of $29,832.
	During the year ended December 31, 2013, the Company issued non-qualified stock option awards under the Company’s Equity Incentive Plan to purchase up to 10,000 shares of the Company’s common stock at an exercise price equal to $4.35 (the closing share price of the Company’s common stock as reported on the OTC Bulletin Board at the close of trading on the grant date) that vest in 3 annual installments and had an aggregate grant date fair value of $25,900 and up to 31,200 shares of the Company’s common stock at an exercise price equal to $4.35 (the closing share price of the Company’s common stock as reported on the OTC Bulletin Board at the close of trading on the grant date) that vest in 4 annual installments and had an aggregate grant date fair value of $80,808.
	The fair value of employee stock options was estimated using the following weighted-average assumptions:
			For the Years Ended December 31,
			2014			2013
	Expected term			5 - 7 years			6.3 - 10 years
	Risk Free interest rate			1.57% - 1.72	%		2.62	%
	Dividend yield			0	%		0	%
	Volatility			27% - 31	%		46.3	%
	Stock option activity
	Options outstanding at December 31, 2014 under the various plans are as follows (in thousands):
	Plan		Total
			Number of
			Options
			Outstanding
			in Plans
	Equity compensation plans not approved by security holders			900
	Equity Incentive Plan			444
				1,344
	A summary of activity under all option Plans for the years ended December 31, 2014 and 2013 is presented below (in thousands, except per share data):
			Number of			Weighted-			Weighted-		Aggregate
Shares			Average			Average			Intrinsic
			Exercise Price			Contractual Term			Value
Outstanding at January 1, 2013			1,132		$	2.06
Options granted			41			4.35
Options exercised			(43	)		1.57
Options forfeited or expired			(11	)		1.27
Outstanding at December 31, 2013			1,119			2.17
Options granted			252			7
Options exercised			(5	)		1
Options forfeited or expired			(22	)		1.47
Outstanding at December 31, 2014			1,344		$	3.08			6.53	$	-
Exercisable at December 31, 2014			1,013		$	2.17			6.45	$	-
Options available for grants at December 31, 2014			1,301
For the years ended December 31, 2014 and 2013, the Company’s estimated forfeiture rate utilized ranged from 0.01% to 0.02%.
During the years ended December 31, 2014 and 2013, the Company recognized stock-based compensation expense, for the vesting of stock options, of $163,646 and $48,239, respectively. Stock-based compensation expense is included as part of selling, general and administrative expense in the accompanying consolidated statements of operations.
As of December 31, 2014, 1,012,745 common stock options that were granted had vested and 331,555 common stock options were unvested. At December 31, 2014 and 2013, the amount of unamortized stock-based compensation expense on unvested stock options granted to employees and consultants was and $476,828 and $150,037, respectively. The unamortized amounts will be amortized over the remaining vesting period through September 30, 2016.
The Company accounts for share-based awards exchanged for employee services at the estimated grant date fair value of the award. Compensation expense includes the impact of an estimate for forfeitures for all stock options. The Company estimated the fair value of employee stock options using the Black-Scholes-Merton option pricing model. The fair value of employee stock options is being amortized on a straight-line basis over the requisite service periods of the respective awards. The expected term of such stock options represents the average period the stock options are expected to remain outstanding and is based on the expected term calculated using the approach prescribed by SAB 107 for “plain vanilla” options. Through September 30, 2014, the expected stock price volatility for the Company’s stock options was determined by using an average of the historical volatilities of the Company and industry peers. Beginning in the fourth quarter of 2014, the Company began estimating its expected volatility using the weekly trading prices of its own common stock as the Company felt this was a more appropriate measure. The risk-free interest rate assumption is based on the U.S. Treasury instruments whose term was consistent with the expected term of the Company’s stock options. The expected dividend assumption is based on the Company’s history and expectation of dividend payouts.
(Loss) Earnings Per Share
The Company utilizes ASC 260, “Earnings per Share,” (“ASC 260”) to calculate earnings or loss per share. Basic earnings or loss per share is computed by dividing the net income or loss available to common stockholders by the weighted average number of common shares outstanding during the period. Diluted earnings or loss per share is computed using the weighted average number of common shares and, if dilutive, potential common shares outstanding during the period. Potential common shares consist of the incremental common shares issuable upon the exercise of stock options (using the treasury stock method) and the conversion of the Company’s convertible debt and warrants (using the if-converted method). Diluted loss per share excludes the shares issuable upon the exercise of stock options, convertible notes and common stock purchase warrants from the calculation of net loss per share, as their effect is antidilutive.
The following table reconciles the numerator and denominator for the calculation:
		For the years ended
		December 31,
		2014			2013
Net (loss) income - basic		$	(13,852,249	)	$	801,352
Denominator – basic:
Weighted average number of common shares outstanding			16,415,152			12,818,487
Basic (loss) earnings per common share		$	(0.84	)	$	0.06
Net (loss) earnings - diluted		$	(13,852,249	)	$	801,352
Denominator – diluted:
Basic weighted average number of common shares outstanding			16,415,152			12,818,487
Weighted average effect of dilutive securities:
Common share equivalents of outstanding stock options			-			349,428
Common share equivalents of convertible debt			-			-
Common share equivalents of outstanding warrants			-			18,450
Diluted weighted average number of common shares outstanding			16,415,152			13,186,365
Diluted (loss) earnings per common share		$	(0.84	)	$	0.06
Securities excluded from the weighted outstanding calculation because their inclusion would have been antidilutive:
Convertible debt			1,136,364			—
Stock options			1,344,300			6,434
Warrants			1,216,091			4,089

Income_Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2014
Income Tax Disclosure [Abstract]
Income Taxes	Note 10. INCOME TAXES
	The income tax provision (benefit) consists of the following:
		For the Years ended
		December 31,
		2014			2013
	Current:
	Federal	$	-		$	337,016
	State and local		-			29,344
	Utilization of net operating loss carryforward		-			(346,783	)
			-			19,577
	Deferred:
	Federal		(4,337,272	)		202,531
	State and local		(463,060	)		34,178
			(4,800,332	)		236,709
	Change in valuation allowance		5,567,665			(781,077	)
			767,333			(544,368	)
	Income tax provision (benefit)	$	767,333		$	(524,791	)
	The following is a reconciliation of the expected tax expense (benefit) on the U.S. statutory rate to the actual tax expense (benefit) reflected in the accompanying statement of operations:
		For the Years Ended
		December 31,
		2014			2013
	U.S. federal statutory rate		(34.00	)%		34	%
	State and local taxes, net of federal benefit		(2.98	)%		3.63	%
	Amortization of debt discount		—			13.95	%
	Debt conversion inducement		—			40.76	%
	Net operating loss tax adjustment		—			(9.65	)%
	Other permanent differences		0.29	%		3	%
	Alternative minimum tax		—			6.97	%
	Change in valuation allowance		42.55	%		(282.42	)%
	Income tax provision (benefit)		5.86	%		(189.76	)%
	As of December 31, 2014 and 2013, the Company’s deferred tax assets and liabilities consisted of the effects of temporary differences attributable to the following:
		Years Ended December 31,
		2014			2013
	Current deferred tax assets:
	Net operating loss carryforwards	$	4,556,515		$	169,404
	Stock-based compensation expense		507,864			442,813
	Alternative minimum tax credit carryforwards		15,336			19,283
	Reserves and allowances		263,609			97,587
	Inventory		269,865			59,320
	Accrued expenses and deferred income		53,442			8,824
	Severance		27,555			—
	Charitable contributions		1,260			1,317
	Total current deferred tax assets		5,695,446			798,548
	Current deferred tax liabilities:
	Section 481 (a) adjustment		—			(24,450	)
	Property and equipment		—			(7,600	)
	Total current deferred tax liabilities		—			(32,050	)
	Net current deferred tax assets		5,695,446			766,498
	Valuation allowance		(5,695,446	)		—
	Net deferred tax assets	$	—		$	766,498
	In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. After consideration of all of the positive and negative evidence available, management has determined that a valuation allowance of $5,695,446 and $0 are required at December 31, 2014 and 2013, respectively, to reduce the deferred tax assets to amounts that are more likely than not to be realized. Should the factors underlying management’s analysis change, future valuation adjustments to the Company’s net deferred tax assets may be necessary.
	At December 31, 2014 the Company had U.S. federal and state net operating loss carryforwards (“NOLS”) of $12,214,479 and $12,812,444, respectively. At December 31, 2013 the Company had U.S. federal and state NOLS of $251,269 and $1,526,482, respectively. These NOLs expire beginning in 2032. Utilization of our NOLS may be subject to an annual limitation under section 382 and similar state provisions of the Internal Revenue Code due to changes of ownership that may have occurred or that could occur in the future, as defined under the regulations.
	As required by the provisions of ASC 740, the Company recognizes the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the more likely than not threshold, the amount recognized in the consolidated financial statements is the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate settlement with the relevant tax authority. Differences between tax positions taken or expected to be taken in a tax return and the net benefit recognized and measured pursuant to the interpretation are referred to as “unrecognized benefits.” A liability is recognized (or amount of NOL or amount of tax refundable is reduced) for an unrecognized tax benefit because it represents an enterprise’s potential future obligation to the taxing authority for a tax position that was not recognized as a result of applying the provisions of ASC 740.
	If applicable, interest costs and penalties related to unrecognized tax benefits are required to be calculated and would be classified as interest and penalties in general and administrative expense in the statement of operations. As of December 31, 2014 and 2013, no liability for unrecognized tax benefit was required to be reported. No interest or penalties were recorded during the years ended December 31, 2014 and 2013. The Company does not expect any significant changes in its unrecognized tax benefits in the next year. The Company files U.S. federal and Florida, Maryland, Texas, New Jersey and Wisconsin state income tax returns. As of December 31, 2014, the Company’s U.S. and state tax returns remain subject to examination by tax authorities beginning with the tax year ended December 31, 2011.

Commitments_and_Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2014
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 11. COMMITMENTS AND CONTINGENCIES
	Employment Agreements
	On February 19, 2013, the Company entered into an employment agreement with Mr. Jeffrey Holman pursuant to which Mr. Holman will be employed as President of the Company for a term that shall begin on February 19, 2013, and, unless sooner terminated as provided therein, shall end on December 31, 2015; provided that such term of employment shall automatically extend for successive one-year periods unless either party gives at least six months’ advance written notice of its intention not to extend the term of employment. Mr. Holman will receive a base salary of $182,000 for the first two years of the employment agreement. Mr. Holman shall be eligible to participate in the Company’s annual performance based bonus program, as the same may be established from time to time by the Company’s Board of Directors in consultation with Mr. Holman for executive officers of the Company.
	Resignation of Chief Executive Officer and Appointment of New Chief Executive Officer
	Effective April 25, 2014, Kevin Frija resigned as the Company’s Chief Executive Officer and the Company’s Board of Directors appointed the Company’s President and incumbent member of the Board, Jeffrey Holman, as the Company’s new Chief Executive Officer. In connection with Mr. Frija’s resignation as Chief Executive Officer, the Board approved severance payments to Mr. Frija in an aggregate amount equal to one year of base salary at the rate of $159,000 per annum payable in installments in accordance with the Company’s normal payroll schedule conditioned upon his execution and delivery of a general release to the Company, which has become irrevocable in accordance with its terms and applicable law, and his compliance with the non-solicitation, confidentiality and non-competition covenants of his Employment Agreement dated February 27, 2012 with the Company until April 24, 2015 in certain respects and indefinitely in other respects. During the year ended December 31, 2014 the Company accrued severance expense in the amount of $167,003, which is included as part of the selling, general and administrative expenses in accompanying consolidated statements of operations in connection with Mr. Frija’s resignation. During the year ended December 31, 2014 $89,925 was paid and $77,028 is included in accrued expenses in accompanying consolidated balance sheets.
	Termination of Asset Purchase Agreement With International Vapor Group, Inc.
	On May 14, 2014, the Company and the Company’s wholly-owned subsidiary IVGI Acquisition, Inc., a Delaware corporation (the “Buyer”) entered into the Asset Purchase Agreement with International Vapor Group, Inc. (“IVG”) pursuant to which the Company was to purchase the business of IVG by acquiring substantially all of the assets and assuming certain of the liabilities of IVG in an asset purchase transaction. On July 25, 2014, the Company, the Buyer and the Owners David Epstein, David Herrera and Nicolas Molina, in their capacities as the representatives of the Sellers and Owners, entered into a First Amendment to Asset Purchase Agreement (the “First Amendment”). In connection with the First Amendment, the Company entered into a Secured Promissory Note whereby it loaned IVG $500,000 for working capital purposes. The secured promissory note accrued interest at a rate of 8% per year and was due at the earlier of (a) six months after the date of the termination of the Asset Purchase Agreement or the date the asset purchase closed. During the year ended December 31, 2014, the Company recognized interest income of $17,095 relating to this loan receivable.
	On August 26, 2014, the Company, the Buyer, and the Sellers and David Epstein, David Herrera and Nicolas Molina, in their capacities as the representatives of the Sellers and the owners of International Vapor Group, Inc., entered into a Termination Letter, pursuant to which the parties mutually terminated their previously announced Asset Purchase Agreement entered into on May 14, 2014 and amended on July 25, 2014. The Company and the Sellers mutually terminated the Asset Purchase Agreement because the parties could not agree upon certain operational and financial matters pertaining to the post-closing integration of the Sellers’ business operations. There are no current disputes or disagreements between the Company and the Sellers and neither party is liable for any breakup fees or reimbursement of costs to the other party as a result of the termination of the Asset Purchase Agreement.
	On January 12, 2015, the Company entered into an agreement with IVG whereby the Company agreed to reduce the principal amount of the loan receivable by $50,000 if IVG were to remit payment of all principal and interest accrued on the loan receivable within one day. The Company included the write-down of the loan receivable in selling, general and administrative expenses on the consolidated statement of operations for the year ended December 31, 2014. On January 13, 2015, IVG paid the Company in full.
	Lease Commitments
	The Company leases its Florida office and warehouse facilities under a twenty-four month lease agreement with an initial term through April 30, 2013 that the Company extended in March 2014 when it exercised the second of three successive one-year renewal options. The lease provides for annual rental payments of $144,000 per annum (including 45 days of total rent abatement) during the initial twenty-four month term and annual rental payments of $151,200, $158,760 and $174,636 during each of the three one-year renewal options. In October 2013, the Company amended the master lease to include an additional approximately 2,200 square feet for an additional annual rental payment of $18,000 subject to the same renewal options and other terms and conditions set forth in the master lease.
	During the year ended December 31, 2014, the Company entered into nine (9) real estate leases for eight (8) new retail kiosks and one (1) new retail store. The kiosks opened during the fourth quarter of 2014 and the store is scheduled to open during 2015. The kiosks are located in malls in Florida, Maryland, New Jersey and Texas. The retail store is located in Ft. Lauderdale, FL. Under these leases, the initial lease terms range from one to five years, the Company is required to pay base and percentage rents and the Company is required to pay for common area and maintenance charges and utilities.
	Future minimum lease payments under non-cancelable operating that have initial or remaining terms in excess of one year at December 31, 2014 are due as follows:
			Operating
			Leases
	2015		$	572,798
	2016			307,488
	2017			300,279
	2018			253,841
	2019			203,964
	Total		$	1,638,370
	Rent expense for the years ended December 31, 2014 and 2013 was $307,110 and $162,498, respectively.
	Legal Proceedings
	From time to time the Company may be involved in various claims and legal actions arising in the ordinary course of our business.
	On May 15, 2011, the Company became aware that Ruyan Investment (Holdings) Limited (“Ruyan”) had named the Company, along with three other sellers of electronic cigarettes in a lawsuit filed in the U.S. District Court for the Central District of California alleging infringement of U.S. Patent No. 7,832,410, entitled “Electronic Atomization Cigarette” against the Company’s Fifty-One Trio products. In that lawsuit, which was initially filed on January 12, 2011, Ruyan was unsuccessful in bringing suit against the Company due to procedural rules of the court. Subsequent thereto, on July 29, 2011, Ruyan filed a new lawsuit in which it named the Company, along with seven other sellers of electronic cigarettes, alleging infringement of the same patent. On March 1, 2013, the Company and Ruyan settled this multi-defendant federal patent infringement lawsuit as to them pursuant to a settlement agreement by and between them. Under the terms of the settlement agreement:
		●	The Company acknowledged the validity of Ruyan’s U.S. Patent No. 7,832,410 for “Electronic Atomization Cigarette” (the “410 Patent”), which had been the subject of Ruyan’s patent infringement claim against the Company;
		●	The Company paid Ruyan a lump sum payment of $12,000 for the Company’s previous sales of electronic cigarettes based on the 410 Patent; and
		●	On March 1, 2013, in conjunction with releasing one another (including their respective predecessors, successors, officers, directors and employees, among others) from claims related to the 410 Patent, the Company and Ruyan filed a Stipulated Judgment and Permanent Injunction with the above Court dismissing with prejudice all claims which have been or could have been asserted by them in the lawsuit.
	On June 22, 2012, Ruyan filed a second lawsuit against the Company alleging infringement of U.S. Patent No. 8,156,944, entitled “Aerosol Electronic Cigarette” (the “944 Patent”). Ruyan also filed separate cases for patent infringement against nine other defendants asserting infringement of the ‘944 Patent. Ruyan’s second lawsuit against the Company known as Ruyan Investment (Holdings) Limited v. Vapor Corp., No. 12-cv-5466, is pending in the United States District Court for the Central District of California. All of these lawsuits have been consolidated for discovery and pre-trial purposes. The Company intends to vigorously defend against this lawsuit.
	On February 25, 2013, Ruyan’s second patent infringement lawsuit against the Company as well as all of the other consolidated lawsuits were stayed as a result of the Court granting a stay in one of the consolidated lawsuits. The Court granted the motion to stay Ruyan’s separate lawsuits against the Company and the other defendants based on the filing of a request for inter partes reexamination of the 944 Patent at the U.S. Patent and Trademark Office. As a result of the stay, all of the consolidated lawsuits involving the 944 Patent have been stayed until the reexamination is completed. As a condition to granting the stay of all the lawsuits, the Court required any other defendant who desires to seek reexamination of the 944 Patent and potentially seek another stay (or an extension of the existing stay) based on any such reexamination to seek such reexamination no later than July 1, 2013. Two other defendants sought reexamination of the 944 Patent before expiration of such Court-imposed deadline of July 1, 2013. All reexamination proceedings of the 944 Patent have been stayed by the United States Patent and Trademark Office Patent Trial and Appeal Board pending its approval of one or more of them. On December 24, 2014, the Patent Trial and Appeal Board issued its ruling that all of the challenged claims in the reexamination proceedings of the ‘944 patent were invalid except for one claim. To the extent claim 11 is asserted against the Company, the Company will vigorously defend itself against such allegations. Currently, the case remains stayed.
	On March 5, 2014, Fontem Ventures, B.V. and Fontem Holdings 1 B.V. (the successors to Ruyan) filed a complaint against the Company in the U.S. District Court for the Central District of California, captioned Fontem Ventures B.V., et al. v. Vapor Corp., No. 14-cv-1650. The complaint alleges infringement of U.S. Patent No. 8,365,742, entitled “Aerosol Electronic Cigarette”, U.S. Patent No. 8,375,957, entitled “Electronic Cigarette” (the “957 Patent”), U.S. Patent No. 8,393,331, entitled “Aerosol Electronic Cigarette” (the “331 Patent”) and U.S. Patent No. 8,490,628, entitled “Electronic Atomization Cigarette” (the “628 Patent”). On April 8, 2014, plaintiffs amended their complaint to add U.S. Patent No. 8,689,805, entitled “Electronic Cigarette” (the “805 Patent”). The products accused of infringement by plaintiffs are various Krave, Fifty-One and Hookah Stix products and parts. Nine other companies were also sued in separate lawsuits alleging infringement of one or more of the patents listed above. The Company filed its Answer and Counterclaims on May 1, 2014 and believes the claims are without merit. Other defendants have filed petitions for inter partes reexamination of the 331, 628 and 805 Patents at the U.S. Patent and Trademark Office, which petitions are pending.
	On October 21, 2014, Fontem Ventures B.V. and Fontem Holdings 1 B.V. filed a complaint against the Company in the U.S. District Court for the Central District of California, captioned Fontem Ventures B.V., et al. v. Vapor Corp., No. 14-cv-8155. The complaint alleges infringement of United States Patent No. 8,863,752, entitled “Electronic Cigarette”. The products accused of infringement by plaintiffs are various Krave and Fifty-One products and parts. On January 15, 2015, the Company filed its Answer and Counterclaims. The Company will vigorously defend itself against such allegations.
	On December 2, 2014, Fontem Ventures B.V. and Fontem Holdings 1 B.V. filed a complaint against the Company in the U.S. District Court for the Central District of California, captioned Fontem Ventures B.V., et al. v. Vapor Corp., No. 14-cv-09267. The Compliant alleges infringement by plaintiffs are various Krave, Vapor X and Fifty-One products and parts. Fontem amended its compliant on December 16, 2014, to allege infringement of United States Patent No. 8,910,641, entitled “Electronic Cigarette” against the same products. On January 15, 2015, the Company filed its Answer and Counterclaims. The Company will vigorously defend itself against such allegations.
	All of the above referenced cases filed by Fontem have been consolidated and are currently scheduled for trail in November 2014. The parties are currently in active fact discovery and claim construction.
	Purchase Commitments
	At December 31, 2014 and 2013, the Company has vendor deposits of $319,563 and $782,363, respectively, and vendor deposits are included as a component of prepaid expenses and vendor deposits on the consolidated balance sheets included herewith.

Concentration_of_Credit_Risk

Concentration of Credit Risk	12 Months Ended
	Dec. 31, 2014
Risks and Uncertainties [Abstract]
Concentration of Credit Risk	Note 12. CONCENTRATION OF CREDIT RISK
	At December 31, 2014 accounts receivable balances included concentrations from seven customers that had balances of an amount greater than 10%. The amounts ranged from $27,729 to $177,200. At December 31 2013, accounts receivable balances included a concentration from one customer in the amount of $268,768, which was an amount greater than 10% of the total net accounts receivable balance.
	Beginning the first quarter of 2012, the Company began selling electronic cigarettes in the country of Canada exclusively through a Canadian distributor. For the years ended December 31, 2014 and 2013, the Company had sales in excess of 10% to this Canadian distributor of $2,912,525 and $3,847,310, respectively. For the year ended December 31, 2014 one other customer accounted for sales in excess of 10% with sales of $1,536,050. No other customer accounted for sales of 10% for the year ended December 31, 2013.

Subsequent_Events

Subsequent Events	12 Months Ended
	Dec. 31, 2014
Subsequent Events [Abstract]
Subsequent Events	Note 13. SUBSEQUENT EVENTS
	The Company evaluates events that have occurred after the balance sheet date but before the consolidated financial statements are issued. Based upon the evaluation, the Company did not identify any recognized or non-recognized subsequent events that would have required adjustment or disclosure in the consolidated financial statements other disclosed.
	The merger closed on March 4, 2015. Prior to the closing of the Merger, Vapor and Vaporin entered into a Securities Purchase Agreement (“Securities Purchase Agreement”) with certain accredited investors providing for the sale of $350,000 of Vaporin’s Convertible Notes (the “Notes”). On January 29, 2015, the Company issued the notes. The Note accrues interest on the outstanding principal at an annual rate of 12%. The principal and accrued interest on the Note is due and payable on January 29, 2016 (the “Maturity Date”) The Note will not be convertible until such time as the Nasdaq Stock Market (“Nasdaq”) approves the listing of the shares to be issued upon conversion of the Note. In no event will the number of shares of the Company’s common stock issuable upon conversion of the Note exceed 19.99% of the Company’s issued and outstanding common stock, regardless of the conversion price.
	In connection with the Merger, on March 3, 2015, the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain accredited investors providing for the sale of $3,500,960 in shares of the Company’s Common Stock, par value $0.001 per share at a price of $1.02 per share. The Company also issued Warrants to purchasers of the shares to acquire an aggregate of 2,735,132 shares of the Company’s Common Stock with an exercise price of $1.28 per share. The shares and Warrants were issued and sold through an exempt private securities offering to certain accredited investors.
	Under the Purchase Agreement, the Company made certain customary representations and warranties to the purchasers concerning the Company and its operations. The Company has also agreed to register the Common Stock and the Warrants for resale pursuant to an effective registration statement which must be filed within 45 days of March 3, 2015 and must be effective by the later of (i) the 90th day following March 3, 2015 (if no SEC review) or (ii) the 120th day following March 3, 2015 (if subject to SEC review). If the Form S-3 Registration Statement is not effective for resales for more than 10 consecutive days or more than 15 days in any 12 month period during the registration period (i.e., the earlier of the date on which the shares have been sold or are eligible for sale under SEC Rule 144 without restriction), we are required to pay the investors (other than our participating officers and directors) liquidated damages in cash equal to 1.5% of the aggregate purchase price paid by the investors for the shares for every 30 days or portion thereof until the default is cured. Such cash payments could be as much as $52,500 for every 30 days.

Summary_of_Significant_Account1

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2014
Accounting Policies [Abstract]
Principles of consolidation	Principles of consolidation
	The accompanying consolidated financial statements include the accounts of the Company, its wholly owned subsidiary, Smoke Anywhere USA, Inc., and its 50% joint venture interest in Emagine the Vape Store, LLC. All significant intercompany transactions and balances were eliminated.
Use of estimates in the preparation of the financial statements	Use of estimates in the preparation of financial statements
	The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of net revenue and expenses during the reporting periods. Actual results could differ from those estimates. These estimates and assumptions include allowances, reserves and write-downs of receivables and inventory, valuing equity securities and hybrid instruments, share-based payment arrangements, deferred taxes and related valuation allowances, and the preliminary valuation of the net assets acquired subsequent to December 31, 2014 in the Merger. Certain of our estimates could be affected by external conditions, including those unique to our industry, and general economic conditions. It is possible that these external factors could have an effect on our estimates that could cause actual results to differ from our estimates. The Company re-evaluates all of its accounting estimates at least quarterly based on these conditions and records adjustments when necessary.
Revenue recognition	Revenue recognition
	The Company recognizes revenue from product sales or services rendered when the following four revenue recognition criteria are met: persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, the selling price is fixed or determinable, and collectability is reasonably assured.
	Product sales and shipping revenues, net of promotional discounts, rebates, and return allowances, are recorded when the products are shipped, title passes to customers and collection is reasonably assured. Retail sales to customers are made pursuant to a sales contract that provides for transfer of both title and risk of loss upon the Company’s delivery to the carrier. Return allowances, which reduce product revenue, are estimated using historical experience. Revenue from product sales and services rendered is recorded net of sales and consumption taxes.
	The Company periodically provides incentive offers to its customers to encourage purchases. Such offers include current discount offers, such as percentage discounts off current purchases, inducement offers, such as offers for future discounts subject to a minimum current purchase, and other similar offers. Current discount offers, when accepted by the Company’s customers, are treated as a reduction to the purchase price of the related transaction, while inducement offers, when accepted by its customers, are treated as a reduction to the purchase price of the related transaction based on estimated future redemption rates. Redemption rates are estimated using the Company’s historical experience for similar inducement offers. The Company reports sales, net of current discount offers and inducement offers on its consolidated statements of operations.
Shipping and Handling Costs	Shipping and Handling Costs
	The Company policy is to provide free standard shipping and handling for most orders shipped during the year. Shipping and handling costs incurred are recognized in selling, general and administrative expenses. Such amounts aggregated $661,583 and $658,586 for the years ended December 31, 2014 and 2013 respectively.
	In certain circumstances, shipping and handling costs are charged to the customer and recognized in sales, net. The amounts recognized for the years ended December 31, 2014 and 2013 were $71,225 and $129,761, respectively.
Cash and Cash Equivalents	Cash and Cash Equivalents
	The Company considers all highly liquid investments with a maturity of three months or less when purchased to be cash equivalents. For financial statement purposes, investments in money market funds are considered a cash equivalent and are included in cash and cash equivalents. The Company maintains its cash and cash equivalents at high credit quality federally insured financial institutions, with balances, at times, in excess of the Federal Deposit Insurance Corporation’s insurance coverage limit of $250,000 per federally insured financial institution. Management believes that the financial institutions that hold the Company’s deposits are financially sound and, therefore, pose a minimum credit risk. The Company has not experienced any losses in such accounts. At December 31, 2014 and 2013, the Company did not hold cash equivalents.
Accounts Receivable	Accounts Receivable
	Accounts receivable, net is stated at the amount the Company expects to collect. The Company provides a provision for allowances that includes returns, allowances and doubtful accounts equal to the estimated uncollectible amounts. The Company estimates its provision for allowances based on historical collection experience and a review of the current status of trade accounts receivable. It is reasonably possible that the Company’s estimate of the provision for allowances will change.
Due From Merchant Credit Card Processor	Due From Merchant Credit Card Processor
	Due from merchant credit card processor represents monies held by the Company’s credit card processors. The funds are being held by the merchant credit card processors pending satisfaction of their hold requirements and expiration of charge backs/refunds from customers.
Inventories	Inventories
	Inventories are stated at the lower of cost (determined by the first-in, first-out method) or market. If the cost of the inventories exceeds their market value, provisions are recorded to write down excess inventory to its net realizable value. The Company’s inventories consist primarily of merchandise available for resale.
Property and Equipment	Property and equipment
	Property and equipment is stated at cost less accumulated depreciation. Depreciation is calculated using the straight-line method over the expected useful life of the respective asset, after the asset is placed in service. The Company generally uses the following depreciable lives for its major classifications of property and equipment:
	Description	Useful Lives
	Warehouse fixtures	2 years
	Warehouse equipment	5 years
	Furniture and fixtures	5 years
	Computer hardware	3 years
Impairment of Long Lived Assets	Impairment of Long-Lived Assets
	The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying value of the asset may not be recoverable. In connection with this review, the Company also reevaluates the depreciable lives for these assets. The Company assesses recoverability by determining whether the net book value of the related asset will be recovered through the projected undiscounted future cash flows of the asset. If the Company determines that the carrying value of the asset may not be recoverable, it measures any impairment based on the projected future discounted cash flows as compared to the asset’s carrying value. Through December 31, 2014, the Company has not recorded any impairment charges on its long-lived assets.
Advertising	Advertising
	The Company expenses advertising cost as incurred.
Warranty liability	Warranty liability
	The Company’s limited lifetime warranty policy generally allows its end users and retailers to return defective purchased rechargeable products in exchange for new products. The Company estimates a reserve for warranty liability and records that reserve amount as a reduction of revenues and as an accrued expense on the accompanying consolidated balance sheets. The warranty claims and expense was not deemed material for the years ended December 31, 2014 and 2013.
Income Taxes	Income taxes
	The Company uses the asset and liability method of accounting for income taxes in accordance with ASC 740, “Income Taxes” (“ASC 740.”) Under this method, income tax expense is recognized as the amount of: (i) taxes payable or refundable for the current year and (ii) future tax consequences attributable to differences between financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the results of operations in the period that includes the enactment date. A valuation allowance is provided to reduce the deferred tax assets reported if based on the weight of available evidence it is more likely than not that some portion or all of the deferred tax assets will not be realized.
Product Development	Product Development
	The Company includes product development expenses relating to the commercialization of new products which are expensed as incurred as part of operating expenses. Product development expenses for the years ended December 31, 2014 and 2013 were approximately $312,000 and $174,000, respectively.
Fair value measurements	Fair value measurements
	The Company applies the provisions of Accounting Standards Codification (“ASC”) 820, “Fair Value Measurements and Disclosures,” (“ASC 820”). The Company’s short term financial instruments include cash, due from merchant credit card processors, accounts receivable, accounts payable and accrued expenses, each of which approximate their fair values based upon their short term nature. The Company’s other financial instruments include notes payable obligations. The carrying value of these instruments approximate fair value, as they bear terms and conditions comparable to market, for obligations with similar terms and maturities.
	ASC 820 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 describes three levels of inputs that may be used to measure fair value: Level 1 – quoted prices in active markets for identical assets or liabilities; Level 2 – quoted prices for similar assets and liabilities in active market or inputs that are observable; and Level 3 – inputs that are unobservable.
Stock-Based Compensation	Stock-Based Compensation
	The Company accounts for stock-based compensation under ASC 718, “Compensation-Stock Compensation” (“ASC 718”). These standards define a fair value based method of accounting for stock-based compensation. In accordance with ASC Topic 718, the cost of stock-based compensation is measured at the grant date based on the value of the award and is recognized over the vesting period. The value of the stock-based award is determined using the Black-Scholes-Merton valuation model, whereby compensation cost is the fair value of the award as determined by the valuation model at the grant date or other measurement date. The resulting amount is charged to expense on the straight-line basis over the period in which the Company expects to receive the benefit, which is generally the vesting period. The Company considers many factors when estimating expected forfeitures, including types of awards, employee class, and historical experience.
Derivative Instruments	Derivative Instruments
	The Company accounts for free-standing derivative instruments and hybrid instruments that contain embedded derivative features in accordance with ASC Topic No. 815, “Accounting for Derivative Instruments and Hedging Activities,” (“ASC 815”) as well as related interpretations of this topic. In accordance with this topic, derivative instruments and hybrid instruments are recognized as either assets or liabilities in the balance sheet and are measured at fair values with gains or losses recognized in earnings. Embedded derivatives that are not clearly and closely related to the host contract are bifurcated and are recognized at fair value with changes in fair value recognized as either a gain or loss in earnings. The Company determines the fair value of derivative instruments and hybrid instruments based on available market data using appropriate valuation models, giving consideration to all of the rights and obligations of each instrument.
	The Company estimates fair values of derivative instruments and hybrid instruments using various techniques (and combinations thereof) that are considered to be consistent with the objective of measuring fair values. In selecting the appropriate technique, the Company considers, among other factors, the nature of the instrument, the market risks that it embodies and the expected means of settlement. For less complex instruments, such as free-standing warrants, the Company generally uses the Black-Scholes-Merton valuation model, adjusted for the effect of dilution, because it embodies all of the requisite assumptions (including trading volatility, estimated terms, dilution and risk free rates) necessary to fair value these instruments. Estimating fair values of derivative financial instruments requires the development of significant and subjective estimates that may, and are likely to, change over the duration of the instrument with related changes in internal and external market factors. In addition, option-based techniques (such as the Black-Scholes-Merton valuation model) are highly volatile and sensitive to changes in the trading market price of the Company’s common stock. Since derivative financial instruments are initially and subsequently carried at fair values, the Company’s income (loss) going forward will reflect the volatility in these estimates and assumption changes. Under ASC 815, increases in the trading price of the Company’s common stock and increases in fair value during a given financial quarter result in the application of non-cash derivative expense. Conversely, decreases in the trading price of the Company’s common stock and decreases in trading fair value during a given financial quarter result in the application of non-cash derivative income.
Convertible Debt Instruments	Convertible Debt Instruments
	The Company accounts for convertible debt instruments when the Company has determined that the embedded conversion options should not be bifurcated from their host instruments in accordance with ASC 470-20 “Debt with Conversion and Other Options”. The Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. The Company amortizes the respective debt discount over the term of the notes, using the straight-line method, which approximates the effective interest method. The Company records, when necessary, induced conversion expense, at the time of conversion for the difference between the reduced conversion price per share and the original conversion price per share.
Lease Accounting	Lease Accounting
	The Company evaluates each lease for classification as either a capital lease or an operating lease. If substantially all of the benefits and risks of ownership have been transferred to the Company as lessee, the Company records the lease as a capital lease at its inception. The Company performs this evaluation at the inception of the lease and when a modification is made to a lease. If the lease agreement calls for a scheduled rent increase during the lease term, the Company recognizes the lease expense on a straight-line basis over the lease term. The Company determines the straight-line rent impact of an operating lease upon inception of the lease.
Recent Accounting Pronouncements	Recent Accounting Pronouncements
	The Financial Accounting Standards Board (“FASB”) has issued Accounting Standards Update (“ASU”) No. 2014-12, Compensation – Stock Compensation (Topic 718): Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period. This ASU requires that a performance target that affects vesting, and that could be achieved after the requisite service period, be treated as a performance condition. As such, the performance target should not be reflected in estimating the grant date fair value of the award. This update further clarifies that compensation cost should be recognized in the period in which it becomes probable that the performance target will be achieved and should represent the compensation cost attributable to the period(s) for which the requisite service has already been rendered. The amendments in this ASU are effective for annual periods and interim periods within those annual periods beginning after December 15, 2015. Earlier adoption is permitted. The adoption of this standard is not expected to have a material impact on the Company’s consolidated financial position and results of operations.
	The FASB has issued ASU No. 2014-09, Revenue from Contracts with Customers. This ASU supersedes the revenue recognition requirements in Accounting Standards Codification 605 - Revenue Recognition and most industry-specific guidance throughout the Codification. The standard requires that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. This ASU is effective on January 1, 2017 and should be applied retrospectively to each prior reporting period presented or retrospectively with the cumulative effect of initially applying the ASU recognized at the date of initial application. The Company is currently evaluating the potential impact, if any, the adoption of this standard will have on the Company’s consolidated financial position and results of operations.
	The FASB has issued ASU No. 2014-15, Presentation of Financial Statements-Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern. The guidance, which is effective for annual reporting periods ending after December 15, 2016, extends the responsibility for performing the going-concern assessment to management and contains guidance on how to perform a going-concern assessment and when going-concern disclosures would be required under U.S. GAAP. The Company has elected to early adopt the provisions of ASU 2014-15 in connection with the issuance of these consolidated financial statements. Information regarding the substantial doubt relating to the Company’s ability to continue as a going concern has been disclosed in Note 2.

Merger_With_Vaporin_Inc_Tables

Merger With Vaporin, Inc. (Tables)	12 Months Ended
	Dec. 31, 2014
Business Combinations [Abstract]
Schedule of Pro Forma Consolidated Results of Operations	The following table presents the unaudited pro-forma financial results, as if the acquisition of Vaporin had been completed as of January 1, 2013 and 2014:
		For the Years Ended
		December 31,
		2014			2013
	Revenues	$	20,253,052		$	28,259,309
	Net (loss) income	$	(19,595,702	)	$	415,316
	Loss per share - basic and diluted	$	(0.59	)	$	0.01

Property_and_Equipment_Tables

Property and Equipment (Tables)	12 Months Ended
	Dec. 31, 2014
Property, Plant and Equipment [Abstract]
Schedule of Property and Equipment	Property and equipment consists of the following:
		December 31,
		2014			2013
	Computer hardware	$	389,373		$	12,471
	Furniture and fixtures		347,612			19,821
	Warehouse fixtures		7,564			7,564
	Warehouse equipment		16,708			16,708
	Leasehold improvements		35,076			-
			796,333			56,564
	Less: accumulated depreciation and amortization		(84,314	)		(27,879	)
		$	712,019		$	28,685

Capital_Lease_Obligations_Tabl

Capital Lease Obligations (Tables)	12 Months Ended
	Dec. 31, 2014
Leases [Abstract]
Future Minimum Lease Payments Under Non-cancelable Capital Leases	Future minimum lease payments under non-cancelable capital leases that have initial or remaining terms in excess of one year at December 31, 2014 are due as follows:
		Capital
		Lease
	2015	$	75,485
	2016		75,485
	2017		62,904
	Total		213,874
	Amounts representing interest payments		(42,416	)
	Present value of future minimum payments		171,458
	Current portion of capital lease obligations		(52,015	)
	Capital lease obligations, long term	$	119,443

Stockholders_Equity_Tables

Stockholders' Equity (Tables)	12 Months Ended
	Dec. 31, 2014
STOCKHOLDERS' EQUITY:
Summary of Warrant Activity	A summary of warrant activity for the years ended December 31, 2014 and 2013 is presented below:
		Number of			Weighted-			Weighted-		Aggregate
		Warrants			Average			Average		Intrinsic
					Exercise Price			Contractual		Value
								Term
	Outstanding at January 1, 2013		10,677		$	1.08
	Warrants granted		205,203			3.34
	Warrants exercised		—			—
	Warrants forfeited or expired		—			—
	Outstanding at December 31, 2013		215,880		$	3.23
	Warrants granted		1,193,181			2
	Warrants exercised		(192,970	)		3.3
	Warrants forfeited or expired		—			—
	Outstanding at December 31, 2014		1,216,091		$	2.01			5	$	—
	Exercisable at December 31, 2014		215,620		$	3.23			5	$	—
Fair Value of Employee Stock Options Estimated Using Weighted-Average Assumptions	The fair value of employee stock options was estimated using the following weighted-average assumptions:
		For the Years Ended December 31,
		2014			2013
	Expected term		5 - 7 years			6.3 - 10 years
	Risk Free interest rate		1.57% - 1.72	%		2.62	%
	Dividend yield		0	%		0	%
	Volatility		27% - 31	%		46.3	%
Summary of Stock Option Outstanding under Various Plans	Options outstanding at December 31, 2014 under the various plans are as follows (in thousands):
	Plan	Total
		Number of
		Options
		Outstanding
		in Plans
	Equity compensation plans not approved by security holders		900
	Equity Incentive Plan		444
			1,344
Summary of Stock Option Activity Under All Option Plans	A summary of activity under all option Plans for the years ended December 31, 2014 and 2013 is presented below (in thousands, except per share data):
		Number of			Weighted-			Weighted-		Aggregate
		Shares			Average			Average		Intrinsic
					Exercise Price			Contractual Term		Value
	Outstanding at January 1, 2013		1,132		$	2.06
	Options granted		41			4.35
	Options exercised		(43	)		1.57
	Options forfeited or expired		(11	)		1.27
	Outstanding at December 31, 2013		1,119			2.17
	Options granted		252			7
	Options exercised		(5	)		1
	Options forfeited or expired		(22	)		1.47
	Outstanding at December 31, 2014		1,344		$	3.08			6.53	$	-
	Exercisable at December 31, 2014		1,013		$	2.17			6.45	$	-
	Options available for grants at December 31, 2014		1,301
Reconciliation of Numerator and Denominator for Calculation of Earnings Per Share	The following table reconciles the numerator and denominator for the calculation:
		For the years ended
		December 31,
		2014			2013
	Net (loss) income - basic	$	(13,852,249	)	$	801,352
	Denominator – basic:
	Weighted average number of common shares outstanding		16,415,152			12,818,487
	Basic (loss) earnings per common share	$	(0.84	)	$	0.06
	Net (loss) earnings - diluted	$	(13,852,249	)	$	801,352
	Denominator – diluted:
	Basic weighted average number of common shares outstanding		16,415,152			12,818,487
	Weighted average effect of dilutive securities:
	Common share equivalents of outstanding stock options		-			349,428
	Common share equivalents of convertible debt		-			-
	Common share equivalents of outstanding warrants		-			18,450
	Diluted weighted average number of common shares outstanding		16,415,152			13,186,365
	Diluted (loss) earnings per common share	$	(0.84	)	$	0.06
	Securities excluded from the weighted outstanding calculation because their inclusion would have been antidilutive:
	Convertible debt		1,136,364			—
	Stock options		1,344,300			6,434
	Warrants		1,216,091			4,089

Income_Taxes_Tables

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2014
Income Tax Disclosure [Abstract]
Schedule of Components of Income Tax Provision	The income tax provision (benefit) consists of the following:
		For the Years ended
		December 31,
		2014			2013
	Current:
	Federal	$	-		$	337,016
	State and local		-			29,344
	Utilization of net operating loss carryforward		-			(346,783	)
			-			19,577
	Deferred:
	Federal		(4,337,272	)		202,531
	State and local		(463,060	)		34,178
			(4,800,332	)		236,709
	Change in valuation allowance		5,567,665			(781,077	)
			767,333			(544,368	)
	Income tax provision (benefit)	$	767,333		$	(524,791	)
Schedule of Effective Income Tax Rate Reconciliation	The following is a reconciliation of the expected tax expense (benefit) on the U.S. statutory rate to the actual tax expense (benefit) reflected in the accompanying statement of operations:
		For the Years Ended
		December 31,
		2014			2013
	U.S. federal statutory rate		(34.00	)%		34	%
	State and local taxes, net of federal benefit		(2.98	)%		3.63	%
	Amortization of debt discount		—			13.95	%
	Debt conversion inducement		—			40.76	%
	Net operating loss tax adjustment		—			(9.65	)%
	Other permanent differences		0.29	%		3	%
	Alternative minimum tax		—			6.97	%
	Change in valuation allowance		42.55	%		(282.42	)%
	Income tax provision (benefit)		5.86	%		(189.76	)%
Schedule of Deferred Tax Assets and Liabilities	As of December 31, 2014 and 2013, the Company’s deferred tax assets and liabilities consisted of the effects of temporary differences attributable to the following:
		Years Ended December 31,
		2014			2013
	Current deferred tax assets:
	Net operating loss carryforwards	$	4,556,515		$	169,404
	Stock-based compensation expense		507,864			442,813
	Alternative minimum tax credit carryforwards		15,336			19,283
	Reserves and allowances		263,609			97,587
	Inventory		269,865			59,320
	Accrued expenses and deferred income		53,442			8,824
	Severance		27,555			—
	Charitable contributions		1,260			1,317
	Total current deferred tax assets		5,695,446			798,548
	Current deferred tax liabilities:
	Section 481 (a) adjustment		—			(24,450	)
	Property and equipment		—			(7,600	)
	Total current deferred tax liabilities		—			(32,050	)
	Net current deferred tax assets		5,695,446			766,498
	Valuation allowance		(5,695,446	)		—
	Net deferred tax assets	$	—		$	766,498

Commitments_and_Contingencies_

Commitments and Contingencies (Tables)	12 Months Ended
	Dec. 31, 2014
Commitments and Contingencies Disclosure [Abstract]
Future Minimum Lease Payments Under Non-cancelable Operating	Future minimum lease payments under non-cancelable operating that have initial or remaining terms in excess of one year at December 31, 2014 are due as follows:
		Operating
		Leases
	2015	$	572,798
	2016		307,488
	2017		300,279
	2018		253,841
	2019		203,964
	Total	$	1,638,370

Organization_Basis_of_Presenta1

Organization, Basis of Presentation and Recent Developments (Detail Narrative)	0 Months Ended
	Dec. 27, 2013	Dec. 27, 2013	Dec. 31, 2014	Dec. 17, 2014	Dec. 31, 2013	Dec. 29, 2013
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Reverse stock split ratio	ratio of 1-for-5	1-for-5
Share capital, shares authorized	51,000,000	51,000,000				251,000,000
Common stock, shares authorized	50,000,000	50,000,000	50,000,000		50,000,000
Blank check preferred stock	1,000,000	1,000,000	1,000,000		1,000,000
Percentage of ownership	50.00%	50.00%	50.00%	50.00%

Going_Concern_and_Management_P1

Going Concern and Management Plans (Details Narrative) (USD $)	0 Months Ended	12 Months Ended
	Oct. 29, 2013	Dec. 31, 2014	Dec. 31, 2013
Net income		($13,852,249)	$801,352
Accumulated deficit		-15,231,903	-1,379,654
Working capital		127,874	11,657,615
Decrease in working capital			11,529,741
Process from private placement	9,000,000
Vaporin [Member]
Company issued and sold value		25,000,000
March 4, 2015 [Member]
Company issued and sold value		3,500,000
Process from private placement		$2,900,000
Issued common stock during period		3,432,314
Number of warrants to purchase shares		2,735,132

Summary_of_Significant_Account2

Summary of Significant Accounting Policies (Details Narrative) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 17, 2014	Dec. 27, 2013
Accounting Policies [Abstract]
Percentage of ownership	50.00%		50.00%	50.00%
Shipping and handling costs	$661,583	$658,586
Shipping and handling revenues	71,225	129,761
Cash balance insured by FDIC per financial institution	250,000
Product development expenses	$312,000	$174,000

Summary_of_Significant_Account3

Summary of Significant Accounting Policies - Schedule of Property and Equipment (Details)	12 Months Ended
	Dec. 31, 2014
Warehouse Fixtures [Member]
Significant Accounting Policies [Line Items]
Useful lives	2 years
Warehouse Equipment Member]
Significant Accounting Policies [Line Items]
Useful lives	5 years
Furniture and Fixtures [Member]
Significant Accounting Policies [Line Items]
Useful lives	5 years
Computer Hardware [Member]
Significant Accounting Policies [Line Items]
Useful lives	3 years

Merger_With_Vaporin_Inc_Detail

Merger With Vaporin Inc (Details Narrative) (USD $)	0 Months Ended		12 Months Ended
	Dec. 17, 2014	Dec. 17, 2014	Dec. 31, 2014	Dec. 27, 2013
Merger closing date	4-Mar-15
Percentage of receive merger consideration to shareholders	45.00%
Maximum percentage of current premium require to be paid	200.00%
Percentage of ownership	50.00%	50.00%	50.00%	50.00%
Joint Venture [Member]
Proceeds from secured line of credit		$3,000,000
Vaporin [Member]
Number of shares issued for merger			13,591,533
Company issued and sold shares value			25,000,000
Vaporin [Member] | Restricted Stock [Member]
Number of shares issued for merger			910,000
March 4, 2015 [Member]
Company issued and sold shares value			$3,500,000

Merger_With_Vaporin_Inc_Schedu

Merger With Vaporin Inc - Schedule of Pro Forma Consolidated Results of Operations (Details) (Pro Forma [Member], USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Pro Forma [Member]
Revenues	$20,253,052	$28,259,309
Net (loss) income	($19,595,702)	$415,316
Loss per share - basic and diluted	($0.59)	$0.01

Property_and_Equipment_Details

Property and Equipment (Details Narrative) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Property And Equipment Details Narrative
Depreciation expense	$56,435	$11,284

Property_and_Equipment_Schedul

Property and Equipment - Schedule of Property and Equipment (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$796,333	$56,564
Less: accumulated depreciation and amortization	-84,314	-27,879
Property and equipment, net	712,019	28,685
Computer Hardware [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	389,373	12,471
Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	347,612	19,821
Warehouse Fixtures [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	7,564	7,564
Warehouse Equipment Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	16,708	16,708
Leasehold Improvements Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$35,076

Notes_Payable_Details_Narrativ

Notes Payable (Details Narrative) (USD $)	12 Months Ended		0 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Nov. 14, 2014	Oct. 29, 2013	Jun. 19, 2012	Sep. 28, 2012	Jul. 09, 2013	Jul. 11, 2013	Apr. 30, 2013	Nov. 13, 2012	Jul. 09, 2012	Jan. 29, 2013
Common stock, par value	$0.00	$0.00
Deferred financing costs	$139,667
Amortization of deferred financing costs	17,458
Amortization of deferred debt discount	156,250	102,500
Induced conversion expense		299,577
Incremental conversion option intrinsic value benefit
Exercisable at initial exercise prices	$2.17
Proceeds from convertible debt		500,000
$1,250,000 Senior Convertible Notes Payable To Related Parties [Member]
Debt instrument, face amount			1,250,000
Convertible promissory note			1,250,000
Number of shares called by warrants			1,136,364
Common stock, par value			$0.00
Exercise price per share			$2
Interest expense, debt			1,250,000
Percentage of outstanding principal annual rate			7.00%
Notes payable, due date			14-Nov-15
Terms of senior convertible notes customary antidilution description			The terms of the $1,250,000 Senior Convertible Notes included customary anti-dilution protection and also included “piggy-back” registration rights with respect to the shares of common stock underlying the $1,250,000 Senior Convertible Notes and warrants.
Percentage of cash equal of principal amount			115.00%
Deferred financing costs			139,667
Amortization of deferred financing costs	17,458
Senior convertible notes payable, debt discounts	1,250,000
Fair value of basis warrants issued	701,250
Fair value of conversion feature issuance	548,750
Amortization of deferred debt discount	156,250
$1,250,000 Senior Convertible Notes Payable To Related Parties [Member] | Palladium Capital Advisors, LLC [Member]
Number of shares called by warrants	56,818
Exercise price per share	$2
Notes payable, due date	14-Nov-19
Placement agent fee	62,500
300,000 Senior Convertible Notes Payable to Related Parties [Member] | Private Placement [Member]
Debt instrument, face amount				300,000
Interest expense, debt				48,674
Debt converted into stock				281,691
300,000 Senior Convertible Notes Payable to Related Parties [Member] | Securities Purchase Agreements [Member] | Harlan Press And Doron Ziv [Member]
Convertible promissory note					300,000
Percentage of stockholders's grater than officers					10.00%
Issuance of warrants to purchase of common stock					9,303
50,000 Senior Convertible Notes Payable to Related Parties [Member]
Amortization of deferred debt discount	3,530
50,000 Senior Convertible Notes Payable to Related Parties [Member] | Private Placement [Member]
Debt instrument, face amount				50,000
Debt converted into stock				41,667
50,000 Senior Convertible Notes Payable to Related Parties [Member] | Securities Purchase Agreements [Member] | Mr. Frija [Member]
Convertible promissory note						500,000
Interest expense, debt						8,113
Issuance of warrants to purchase of common stock						1,374
350,000 Senior Convertible Notes Payable to Related Parties [Member]
Convertible promissory note							350,000
Percentage of outstanding principal annual rate							18.00%
Notes payable, due date							8-Jul-16
Fair value of conversion feature issuance		3,937					350,000
Amortization of deferred debt discount		4,550
Debt converted into stock				350,000
Percentage of conversion price							110.00%
Incremental conversion option intrinsic value benefit							3,937
Debt discount				350,000			4,550
Exercisable at initial exercise prices							$5.71
350,000 Senior Convertible Notes Payable to Related Parties [Member] | Warrant [Member]
Conversion price per share							$5.71
350,000 Senior Convertible Notes Payable to Related Parties [Member] | Private Placement [Member]
Convertible promissory note				350,000
Interest expense, debt				16,126
Conversion price per share				$3
Debt converted into stock				116,668
Percentage of conversion price				110.00%
Debt conversion converted instrument amount				350,000
Induced conversion expense		246,375
Conversion price amount		350,000
350,000 Senior Convertible Notes Payable to Related Parties [Member] | Securities Purchase Agreements [Member] | Ralph Frija [Member]
Convertible promissory note							200,000
Common stock purchase of warrants							3,373
Amortization of deferred debt discount							10,000
Percentage of stockholders's grater than officers							5.00%
Issuance of warrants to purchase of common stock							1,927
Percentage of obtained by dividing							5.00%
Weighted average closing price per share							$5.19
350,000 Senior Convertible Notes Payable to Related Parties [Member] | Securities Purchase Agreements [Member] | Holman [Member]
Convertible promissory note							100,000
Amortization of deferred debt discount							5,000
Percentage of stockholders's grater than officers							5.00%
Issuance of warrants to purchase of common stock							964
Percentage of obtained by dividing							5.00%
Weighted average closing price per share							$5.19
350,000 Senior Convertible Notes Payable to Related Parties [Member] | Securities Purchase Agreements [Member] | Vaccaro [Member]
Convertible promissory note							50,000
Amortization of deferred debt discount							2,500
Issuance of warrants to purchase of common stock							482
Percentage of obtained by dividing							5.00%
Weighted average closing price per share							$5.19
75,000 Senior Convertible Notes Payable to Related Parties [Member]
Convertible promissory note				75,000
Interest expense, debt				3,957
Fair value of conversion feature issuance		75,000
Amortization of deferred debt discount		825						75,000
Debt conversion converted instrument amount				75,000
Induced conversion expense		53,202
Debt discount								825
Number of stock shares issued during period								75,000
Number convertible debt amended								300,000
Number convertible debt amended 1								50,000
75,000 Senior Convertible Notes Payable to Related Parties [Member] | Private Placement [Member]
Conversion price per share				$3
Debt converted into stock				25,000
Debt conversion converted instrument amount				75,000
75,000 Senior Convertible Notes Payable to Related Parties [Member] | Securities Purchase Agreements [Member] | Vaccaro [Member]
Convertible promissory note								75,000
Notes payable, due date								10-Jul-16
Amortization of deferred debt discount								3,750
Issuance of warrants to purchase of common stock								718
Percentage of obtained by dividing								5.00%
Weighted average closing price per share								$5.23
Exercisable at initial exercise prices								$5.75
Option excercisable date								10-Jul-18
500,000 Senior Convertible Note Payable to Stockholder [Member]
Notes payable, due date									22-Apr-16	8-Jan-14
Conversion price per share									$2.58
Percentage of conversion price									110.00%
Number convertible debt amended										500,000
500,000 Senior Convertible Note Payable to Stockholder [Member] | Ralph Frija [Member]
Notes payable, due date											22-Apr-16
Conversion price per share											$2.58
Percentage of stockholders's grater than officers											5.00%
Percentage of conversion price											110.00%
Proceeds from convertible debt											500,000
Percentage of proceeds excess of initial principal amount											125.00%
500,000 Senior Convertible Note Payable [Member]
Percentage of outstanding principal annual rate												18.00%
Notes payable, due date												28-Jan-16
Conversion price per share												$3.38
Percentage of conversion price												110.00%
Incremental conversion option intrinsic value benefit												79,527
500,000 Senior Convertible Note Payable [Member] | Warrant [Member]
Exercisable at initial exercise prices												$3.38
500,000 Senior Convertible Note Payable [Member] | Securities Purchase Agreements [Member] | Robert John Sali [Member]
Convertible promissory note												500,000
Amortization of deferred debt discount												25,000
Issuance of warrants to purchase of common stock												8,142
Percentage of obtained by dividing												5.00%
Weighted average closing price per share												$3.07
Proceeds from sale of securities												500,000
500,000 Senior Convertible Note Payable [Member] | Private Placement [Member]
Convertible promissory note				50,000
Interest expense, debt				93,267
Debt converted into stock				166,662
50,000 Senior Convertible Note Payable [Member]
Fair value of conversion feature issuance		79,527
Amortization of deferred debt discount		10,131
50,000 Senior Convertible Note Payable [Member] | Private Placement [Member]
Convertible promissory note				50,000
Interest expense, debt				$66,329
Debt converted into stock				148,039
Percentage of conversion price				110.00%

Factoring_Facility_and_Term_Lo1

Factoring Facility and Term Loan Payable (Details Narrative) (USD $)	12 Months Ended		0 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Aug. 16, 2013	Sep. 23, 2014	Aug. 08, 2013
Acquisition of account receivable, percentage of face amount advanced by lender					50.00%
Factoring fee, percentage of gross face amount of purchased account receivable					1.00%
Gross borrowings under Factoring Facility	$0	$407,888
Borrowings outstanding under the Factoring Facility	0	0
Term loan	750,000	478,847
Interest expense	348,975	383,981
2013 Term Loan [Member]
Term loan			750,000
Term loan, maturity date			15-Aug-14
Term loan, annual rate			16.00%
Retention of daily fixed amount from daily collection of merchant credit card receivables			3,346
Interest expense	76,617	44,769
2014 Term Loan [Member]
Term loan	750,000			1,000,000
Term loan, maturity date				30-Sep-15
Term loan, annual rate				14.00%
Interest expense	24,086
Term loan, periodic payment, principal				$83,333

Capital_Lease_Obligations_Deta

Capital Lease Obligations (Details Narrative) (USD $)	12 Months Ended		0 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Oct. 01, 2014
Interest expense associated with capital lease obligation	$4,679
Depreciation expense for equipment held under capital lease obligations	56,435	11,284
Equipment [Member]
Capital lease obligation			179,359
Annual interest on the capital lease obligation			15.80%
Capital lease obligation, repayment terms			36 months maturing on October 17, 2017
Depreciation expense for equipment held under capital lease obligations	9,964
Net book value of equipment held under capital lease obligations	$169,395

Capital_Lease_Obligations_Futu

Capital Lease Obligations - Future Minimum Lease Payments Under Non-cancelable Capital Leases (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Leases [Abstract]
2015	$75,485
2016	75,485
2017	62,904
Total	213,874
Amounts representing interest payments	-42,416
Present value of future minimum payments	171,458
Current portion of capital lease obligations	-52,015
Capital lease obligations, long term	$119,443

Stockholders_Equity_Details_Na

Stockholders' Equity (Details Narrative) (USD $)	0 Months Ended					12 Months Ended		0 Months Ended
	Dec. 27, 2013	Dec. 27, 2013	Oct. 29, 2013	Jun. 15, 2013	Mar. 15, 2013	Dec. 31, 2014	Dec. 31, 2013	Mar. 06, 2014	Apr. 25, 2014	Feb. 03, 2014	Oct. 22, 2013	Nov. 20, 2013
Preferred stock, par value						$0.00	$0.00
Preferred stock, shares authorized	1,000,000	1,000,000				1,000,000	1,000,000
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock, par value						$0.00	$0.00
Common stock, shares authorized	50,000,000	50,000,000				50,000,000	50,000,000
Common stock, voting rights						Each share entitles the holder to one vote
Shares issued for services				57,500	29,500
Grant date fair value of common shares issued						$163,646	$48,239
Proceeds from private placements			9,000,000
Offering cost						1,000,000
Offering cost incurred						110,000
Number of register for resale											3,216,171
Percentage of liquidated damages in cash equal			1.50%
Cash payments			81,489			910,000
Common stock reserved and available for issuance												1,800,000
Reverse stock split	ratio of 1-for-5	1-for-5
Volatility, minimum						27.00%
Volatility, maximum						31.00%
Risk-free interest rate, minimum						15.70%
Risk-free interest rate, maximum						17.20%
Dividend yield						0.00%	0.00%
Common stock exercise price per share						$7	$4.35
Stock-based compensation expense, for the vesting of stock options						163,646	48,239
Stock options granted						1,012,745	331,555
Nonvested stock option						476,828	150,037
Equity Incentive Plan [Member]
Common stock reserved and available for issuance						1,800,000
Reverse stock split						1-for-5 reverse stock split.
Percentage of option grants and/or restricted shares for more than shares subject to Plan						20.00%
Nonqualified Directors [Member]
Number of shares issued during period								60,000
Common stock exercise price per share								$8.30
Weighted average grant date fair value								149,160
Other Nonqualified Directors [Member]
Number of shares issued during period									60,000
Common stock exercise price per share									$6.48
Weighted average grant date fair value									315,720
Nonqualified Stock Option [Member]
Number of shares issued during period							10,000
Common stock exercise price per share							$4.35
Weighted average grant date fair value						29,832	25,900
Minimum [Member]
Expected term						5 years	6 years 3 months 18 days
Estimated forfeiture rate						0.02%
Maximum [Member]
Expected term						7 years	10 years
Estimated forfeiture rate						0.01%
Maximum [Member] | Nonqualified Stock Option [Member]
Number of shares issued during period							31,200
Common stock exercise price per share							$4.35
Weighted average grant date fair value							80,808
Warrant [Member]
Expected term						5 years
Volatility, minimum						30.30%
Volatility, maximum						51.40%
Risk-free interest rate, minimum						0.71%
Risk-free interest rate, maximum						0.90%
Dividend yield						0.00%
Number of warrants exercised						-192,970
Number of cashless common stock shares						142,383
Warrant [Member] | Minimum [Member]
Fair value of stock price						$1
Warrant [Member] | Maximum [Member]
Fair value of stock price						$3.50
Senior Convertible Notes [Member]
Convertible promissory note			1,700,000
Debt converted into stock			780,000
Mr. Kavanaugh [Member]
Shares issued to employees										400,000
Grant date fair value of common shares issued										3,080,000
Stock-based compensation expense, for the vesting of stock options										3,080,000
Mr. Kavanaugh [Member] | Award Vested Immediately Upon Execution of Consulting Agreement [Member]
Shares vested and expected to vest										50,000
Mr. Kavanaugh [Member] | Award Vested On May 3, 2014 [Member]
Shares vested and expected to vest										50,000
Mr. Kavanaugh [Member] | Award Vested On August 3, 2014 [Member]
Shares vested and expected to vest										50,000
Mr. Kavanaugh [Member] | Award Vested On November 3, 2014 [Member]
Shares vested and expected to vest										50,000
Mr. Kavanaugh [Member] | Award Vested In Quarterly Installment From November 3, 2014 [Member]
Shares vested and expected to vest										50,000
Knight Global [Member]
Number of bona fide opportunities										6
Consulting Agreement, term						2 years
Commissions payable in cash, percentage of "net sales"						6.00%
Knight Global [Member] | Termination of Consulting Agreement [Member] | January 24, 2015 [Member]
Stock-based compensation expense						322,067
Shares vested and expected to vest						50,000
Officers And Directors [Member]
Proceeds from private placements											10,000,000
Number of shares issued for private placements											3,333,338
Equity issuance price per share											$3
Nonqualified Stock Option [Member]
Number of shares issued during period						12,000
Common stock exercise price per share						$8.30
Selling, General and Administrative Expenses [Member]
Stock-based compensation expense							87,000
Selling, General and Administrative Expenses [Member] | Knight Global [Member]
Stock-based compensation expense						$1,602,933

Stockholders_Equity_Summary_of

Stockholders' Equity - Summary of Warrant Activity (Details) (Warrant [Member], USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Warrant [Member]
Number of Warrants Outstanding, Beginning Balance	215,880	10,677
Number of Warrants granted	1,193,181	205,203
Number of Warrants exercised	-192,970
Number of Warrants forfeited Or Expired	1,216,091
Number of Warrants outstanding, Ending Balance	215,620	215,880
Weighted Average Exercise Price, Warrants Outstanding, Beginning Balance	$3.23	$1.08
Weighted Average Exercise Price, Warrants granted	$2	$3.34
Weighted Average Exercise Price, Warrants exercised	$3.30
Weighted Average Exercise Price, forfeited Or Expired
Weighted Average Exercise Price, Warrants outstanding, Ending Balance	$2.01	$3.23
Weighted Average Exercise Price, Exercisable	$3.23
Weighted Average Remaining Contractual Terms (Years), Outstanding	5 years
Weighted Average Remaining Contractual Terms (Years), Exercisable	5 years
Aggregate Intrinsic Value, Outstanding
Aggregate Intrinsic Value, Exercisable

Stockholders_Equity_Fair_Value

Stockholders' Equity - Fair Value of Employee Stock Options Estimated Using Weighted-Average Assumptions (Details)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Risk-free interest rate, minimum	15.70%
Risk-free interest rate, maximum	17.20%
Risk-free interest rate		26.20%
Dividend yield	0.00%	0.00%
Volatility		46.30%
Volatility, minimum	27.00%
Volatility, maximum	31.00%
Minimum [Member]
Expected term	5 years	6 years 3 months 18 days
Maximum [Member]
Expected term	7 years	10 years

Stockholders_Equity_Summary_of1

Stockholders' Equity - Summary of Stock Option Outstanding Under Various Plans (Details)	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Number of Options Outstanding in Plans	1,344	1,119	1,132
Equity Compensation Plans Not Approved By Security Holders [Member]
Number of Options Outstanding in Plans	900
Equity Incentive Plan [Member]
Number of Options Outstanding in Plans	444

Stockholders_Equity_Summary_of2

Stockholders' Equity - Summary of Stock Option Activity Under All Option Plans (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
STOCKHOLDERS' EQUITY:
Number of shares, Outstanding, Beginning balance	1,119	1,132
Number of shares, Options Granted	252	41
Number of shares, Options Exercised	-5	-43
Number of shares, Options Forfeited/expired	-22	-11
Number of shares, Outstanding, Ending balance	1,344	1,119
Number of shares, Options Exercisable	1,013
Options available for grants	1,301
Weighted Avg. Exercise Price, Outstanding, Beginning balance	$2.17	$2.06
Weighted Avg. Exercise Price, Options Granted	$7	$4.35
Weighted Avg. Exercise Price, Options Exercised	$1	$1.57
Weighted Avg. Exercise Price, Options Forfeited/expired	$1.47	$1.27
Weighted Avg. Exercise Price, Outstanding, Ending balance	$3.08	$2.17
Weighted Avg. Exercise Price, Exercisable Ending Balance	$2.17
Weighted Avg. Remaining Contractual Life, Options Outstanding	6 years 6 months 11 days
Weighted Avg. Remaining Contractual Life, Options Exercisable	6 years 5 months 12 days
Aggregate Intrinsic Value, Options Outstanding
Aggregate Intrinsic Value, Options Exercisable

Stockholders_Equity_Reconcilia

Stockholders' Equity - Reconciliation of Numerator and Denominator for Calculation of Earnings Per Share (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Net (loss) income - basic	($13,852,249)	$801,352
Weighted average number of common shares outstanding	16,415,152	12,818,487
Basic (loss) earnings per common share	($0.84)	$0.06
Net (loss) earnings - diluted	($13,852,249)	$801,352
Basic weighted average number of common shares outstanding	16,415,152	12,818,487
Common share equivalents of outstanding stock options		349,428
Common share equivalents of convertible debt
Common share equivalents of outstanding warrants		18,450
Diluted weighted average number of common shares outstanding	16,415,152	13,186,365
Diluted (loss) earnings per common share	($0.84)	$0.06
Warrant [Member]
Securities excluded from the weighted outstanding calculation because their inclusion would have been antidilutive:	1,216,091	4,089
Convertible Debt Securities [Member]
Securities excluded from the weighted outstanding calculation because their inclusion would have been antidilutive:	1,136,364
Stock Options [Member]
Securities excluded from the weighted outstanding calculation because their inclusion would have been antidilutive:	1,344,300	6,434

Income_Taxes_Details_Narrative

Income Taxes (Details Narrative) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Valuation allowance	$5,695,446	$0
Net operating loss carry forwards expiration date	expire beginning in 2032.
United State [Member]
Net operating loss carryforwards	12,214,479	251,269
Federal And State [Member]
Net operating loss carryforwards	$12,812,444	$1,526,482

Income_Taxes_Schedule_of_Defer

Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Income Tax Disclosure [Abstract]
Federal		$337,016
State and local		29,344
Utilization of net operating loss carryforward		-346,783
Current (benefit) provision		19,577
Federal	-4,337,272	202,531
State and local	-463,060	34,178
Deferred (benefit) provision	-4,800,332	236,709
Change in valuation allowance	5,567,665	-781,077
Deferred Tax Asset Net Durational	767,333	-544,368
Income tax provision (benefit)	$767,333	($524,791)

Income_Taxes_Schedule_of_Compo

Income Taxes - Schedule of Components of Income Tax Provision (Details)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Income Tax Disclosure [Abstract]
U.S. federal statutory rate	-34.00%	34.00%
State and local taxes net of federal benefit	-2.98%	3.63%
Amortization of debt discount	0.00%	13.95%
Debt conversion inducement	0.00%	40.76%
Net operating loss tax adjustment	0.00%	-9.65%
Other permanent differences	0.29%	3.00%
Alternative minimum tax	0.00%	6.97%
Change in valuation allowance	42.55%	-282.42%
Income tax provision (benefit)	5.86%	-189.76%

Income_Taxes_Schedule_of_Effec

Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Income Tax Disclosure [Abstract]
Net operating loss carryforwards	$4,556,515	$169,404
Stock-based compensation expense	507,864	442,813
Alternative minimum tax credit carryforwards	15,336	19,283
Reserves and allowances	263,609	97,587
Inventory	269,865	59,320
Accrued expenses and deferred income	53,442	8,824
Severance	27,555
Charitable contributions	1,260	1,317
Total current deferred tax assets	5,695,446	798,548
Section 481 (a) adjustment		-24,450
Property and equipment		-7,600
Total deferred tax liabilities		-32,050
Net current deferred tax assets	5,695,446	766,498
Valuation allowance	-5,695,446
Net deferred tax assets		$766,498

Commitments_and_Contingencies_1

Commitments and Contingencies (Details Narrative) (USD $)	12 Months Ended		1 Months Ended	0 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Oct. 31, 2013	Apr. 25, 2014	Feb. 19, 2013	Jul. 25, 2014
	Lease		sqft
Selling, general and administrative expenses	$11,126,759	$6,464,969
Accrued expenses	975,112	420,363
Number of real estate leases	9
Number of new retail store	1
Rent expense	307,110	162,498
Payment to patent	12,000
Vendor deposits	319,563	782,363
Minimum [Member]
Initial lease term	1 year
Maximum [Member]
Initial lease term	5 years
Lease Agreement [Member]
Lease agreement term	24 months
Lease expiration date	30-Apr-13
Lease extended month year	2014-03
Lease renewal options	1 year
Annual rental payments	144,000		18,000
Area of square feet			2,200
Kevin Frija [Member]
Base salary				159,000
Selling, general and administrative expenses	167,003
Salary paid	89,925
Accrued expenses	77,028
Employment Agreements [Member] | Mr. Jeffrey Holman [Member]
Base salary					182,000
Employment agreement term					2 years
Asset Purchase Agreement [Member] | International Vapor Group, Inc [Member]
Secured promissory note						500,000
Debt interest rate						8.00%
Debt due date						6 months
Interest income relating to loan receivable	17,095
Asset Purchase Agreement [Member] | International Vapor Group, Inc [Member] | January 12, 2015 [Member]
Repayment of debt	50,000
Lease Agreement [Member]
Annual rental payments current	151,200
Annual rental payments two	158,760
Annual rental payments three	$174,636

Commitments_and_Contingencies_2

Commitments and Contingencies - Future Minimum Lease Payments Under Non-cancelable Operating (Details) (Operating Leases [Member], USD $)	Dec. 31, 2014
Operating Leases [Member]
2015	$572,798
2016	307,488
2017	300,279
2018	253,841
2019	203,964
Total	$1,638,370

Concentration_of_Credit_Risk_D

Concentration of Credit Risk (Details Narrative) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Accounts receivable	$239,652	$1,802,781
Sales	15,279,859	25,990,228
Accounts Receivable [Member]
Concentration customers	seven customers	one customer
Accounts receivable		268,768
Accounts Receivable [Member] | Maximum [Member]
Concentration risk percentage	10.00%	10.00%
Accounts receivable	177,200
Accounts Receivable [Member] | Minimum [Member]
Accounts receivable	27,729
Sales Revenue, Net [Member]
Concentration customers	one other customer	No other customer
Concentration risk percentage		10.00%
Sales	1,536,050
Sales Revenue, Net [Member] | Canadian Distributor [Member]
Concentration country	Canada
Sales	$2,912,525	$3,847,310
Sales Revenue, Net [Member] | Maximum [Member]
Concentration risk percentage	10.00%
Sales Revenue, Net [Member] | Maximum [Member] | Canadian Distributor [Member]
Concentration risk percentage	10.00%

Subsequent_Events_Details_Narr

Subsequent Events (Details Narrative) (USD $)	0 Months Ended
	Mar. 03, 2015	Mar. 04, 2015	Dec. 31, 2014	Dec. 31, 2013
Common stock par value			$0.00	$0.00
Subsequent Event [Member] | Nasdaq [Member]
Percentage of conversion of note exceed			19.99%
Subsequent Event [Member] | Securities Purchase Agreement [Member]
Convertible notes		$350,000
Debt instrument accrued interest rate		12.00%
Notes payable maturity date		29-Jan-16
Sale of common stock	3,500,960
Common stock par value	$0.00
Common stock price per share	$1.02
Issuance of warrant to purchases of common stock, shares	2,735,132
Warrant exercise price per share	$1.28
Percentage of purchase price	1.50%
Cash payment	$52,500